|
|
|
Scientific Literature, apoptosis
-
Abba MC, Hu Y, Levy CC, Gaddis S, Kittrell FS, Zhang Y, Hill J, Bissonnette RP, Medina D, Brown PH, Aldaz CM 2008 Transcriptomic signature of the chemopreventive bexarotene (rexinoid LGD1069) on mammary gland from three transgenic mouse mammary cancer models.
BMC Med. Genomics 1: 40.
*
-
Abbas AK, Lohr J, Knoechel B, Nagabhushanam V 2004 T cell tolerance and autoimmunity.
Autoimmun. Rev. 3: 471-475.
-
Abdou AG, Hanout HM 2008 Evaluation of survivin and NF-kappaB in psoriasis, an immunohistochemical study.
J. Cutan. Pathol. 35: 445-451.
-
Abe R, Shimizu T, Shibaki A, Nakamura H, Watanabe H, Shimizu H 2003 Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand.
Am. J. Pathol. 162: 1515-1520.
*
-
Abe T, Arai T, Ogawa A, Hiromatsu T, Masuda A, Matsuguchi T, Nimura Y, Yoshikai Y 2004 Kupffer cell-derived interleukin 10 is responsible for impaired bacterial clearance in bile duct-ligated mice.
Hepatology 40: 414-423.
*
-
Abe Y, Yoshikawa T, Kamada H, Shibata H, Nomura T, Minowa K, Kayamuro H, Katayama K, Miyoshi H, Mukai Y, Yoshioka Y, Nakagawa S, Tsunoda SI, Tsutsumi Y 2008 Simple and highly sensitive assay system for TNFR2-mediated soluble- and transmembrane-TNF activity.
J. Immunol. Methods 335: 71-78.
*
-
Aboody KS, Najbauer J, Danks MK 2008 Stem and progenitor cell-mediated tumor selective gene therapy.
Gene Ther. 15: 739-752.
-
Abraham M, Karni A, Dembinsky A, Miller A, Gandhi R, Anderson D, Weiner HL 2008 In vitro induction of regulatory T cells by anti-CD3 antibody in humans.
J. Autoimmun. 30: 21-28.
*
-
Achiron A, Gurevich M, Snir Y, Segal E, Mandel M 2007 Zinc-ion binding and cytokine activity regulation pathways predicts outcome in relapsing-remitting multiple sclerosis.
Clin. Exp. Immunol. 149: 235-242.
*
-
Acosta-Perez G, Maximina Bertha Moreno-Altamirano M, Rodriguez-Luna G, Javier Sanchez-Garcia F 2008 Differential dependence of the ingestion of necrotic cells and TNF-alpha/IL-1beta production by murine macrophages on lipid rafts.
Scand. J. Immunol. 68: 423-429.
*
-
Actis GC, Pazienza P, Rosina F 2008 Mesalamine for inflammatory bowel disease: recent reappraisals.
Inflamm. Allergy Drug Targets 7: 1-5.
-
Adachi M, Ishii H 2002 Role of mitochondria in alcoholic liver injury.
Free Radic. Biol. Med. 32: 487-491.
-
Adams DH, Afford SC 2002 The role of cholangiocytes in the development of chronic inflammatory liver disease.
Front. Biosci. 7: 276-285.
-
Adams DH, Afford SC 2005 Effector mechanisms of nonsuppurative destructive cholangitis in graft-versus-host disease and allograft rejection.
Semin. Liver Dis. 25: 281-297.
-
Adams DH, Afford SC, Lalor PF 2003 Cellular immunoreactions in the development of primary biliary cirrhosis.
Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 27. October 15-16. *
-
Adams JM, Cory S 2007 Bcl-2-regulated apoptosis: mechanism and therapeutic potential.
Curr. Opin. Immunol. 19: 488-496.
-
Adams LS, Seeram NP, Aggarwal BB, Takada Y, Sand D, Heber D 2006 Pomegranate juice, total pomegranate ellagitannins, and punicalagin suppress inflammatory cell signaling in colon cancer cells.
J. Agric. Food Chem. 54: 980-985.
-
Adhami E 2004 Calculating the etiology of systemic lupus erythematosus.
Med. Hypotheses 62: 237-246.
-
Adisen E, Gulekon A, Erdem O, Dursun A, Gurer M 2006 The effects of calcipotriol and methylprednisolone aseponate on bcl-2, p53 and ki-67 expression in psoriasis.
J. Eur. Acad. Dermatol. Venereol. 20: 527-533.
*
-
Adorini L, Daniel KC, Penna G 2006 Vitamin D receptor agonists, cancer and the immune system: an intricate relationship.
Curr. Top. Med. Chem. 6: 1297-1301.
-
Afford SC, Ahmed-Choudhury J, Randhawa S, Russell C, Youster J, Crosby HA, Eliopoulos A, Hubscher SG, Young LS, Adams DH 2001 CD40 activation-induced, Fas-dependent apoptosis and NF-kappaB/AP-1 signaling in human intrahepatic biliary epithelial cells.
FASEB J. 15: 2345-2354.
*
-
Afford SC, Hubscher S, Strain AJ, Adams DH, Neuberger JM 1995 Apoptosis in the human liver during allograft rejection and end-stage liver disease.
J. Pathol. 176: 373-380.
-
Afford SC, Randhawa S, Eliopoulos AG, Hubscher SG, Young LS, Adams DH 1999 CD40 activation induces apoptosis in cultured human hepatocytes via induction of cell surface fas ligand expression and amplifies fas-mediated hepatocyte death during allograft rejection.
J. Exp. Med. 189: 441-446.
*
-
Agalliu I, Suuriniemi M, Prokunina-Olsson L, Johanneson B, Collins FS, Stanford JL, Ostrander EA 2008 Evaluation of a variant in the transcription factor 7-like 2 (TCF7L2) gene and prostate cancer risk in a population-based study.
Prostate 68: 740-747.
-
Agarwal B, Swaroop P, Protiva P, Raj SV, Shirin H, Holt PR 2003 Cox-2 is needed but not sufficient for apoptosis induced by Cox-2 selective inhibitors in colon cancer cells.
Apoptosis 8: 649-654.
*
-
Agarwal K, Czaja AJ, Donaldson PT 2007 A functional Fas promoter polymorphism is associated with a severe phenotype in type 1 autoimmune hepatitis characterized by early development of cirrhosis.
Tissue Antigens 69: 227-235.
*
-
Aggarwal BB 2004 Nuclear factor-kappaB: the enemy within.
Cancer Cell 6: 203-208.
*
-
Aggarwal BB 2003 Signalling pathways of the TNF superfamily: a double-edged sword.
Nat. Rev. Immunol. 3: 745-756.
*
-
Aggarwal BB, Kunnumakkara AB, Harikumar KB, Tharakan ST, Sung B, Anand P 2008 Potential of spice-derived phytochemicals for cancer prevention.
Planta Med. Jul 8 [Epub ahead of print].
-
Aggarwal BB, Sethi G, Nair A, Ichikawa H 2006 Nuclear factor-kB: a holy grail in cancer prevention and therapy.
Current Signal Transduction Therapy 1: 25-52. *
-
Aggarwal BB, Shishodia S, Sandur SK, Pandey MK, Sethi G 2006 Inflammation and cancer: how hot is the link?
Biochem. Pharmacol. 72: 1605-1621.
*
-
Aggarwal BB, Takada Y, Oommen OV 2004 From chemoprevention to chemotherapy: common targets and common goals.
Expert Opin. Investig. Drugs 13: 1327-1338.
-
Agnholt J, Kelsen J, Brandsborg B, Jakobsen NO, Dahlerup JF 2004 Increased production of granulocyte-macrophage colony-stimulating factor in Crohn's disease - a possible target for infliximab treatment.
Eur. J. Gastroenterol. Hepatol. 16: 649-655.
-
Agrawal YP 2005 Low dose naltrexone therapy in multiple sclerosis.
Med. Hypotheses 64: 721-724.
*
-
Aguillon G JC, Cruzat C A, Contreras-Levicoy J, Dotte G A, Pesce R B, Aravena MO, Salazar A L, Catalan M D, Abello C P, Aguirre D A, Llanos M C, Cuchacovich TM 2005 Emergent therapies for rheumatoid arthritis.
Rev. Med. Chil. 133: 969-976.
-
Ahmad R, Raina D, Trivedi V, Ren J, Rajabi H, Kharbanda S, Kufe D 2007 MUC1 oncoprotein activates the IkappaB kinase beta complex and constitutive NF-kappaB signalling.
Nat. Cell Biol. 9: 1419-1427.
*
-
Ahmad W, Panteleyev AA, Christiano AM 1999 The molecular basis of congenital atrichia in humans and mice: mutations in the hairless gene.
J. Investig. Dermatol. Symp. Proc. 4: 240-243.
*
-
Ahn KS, Sethi G, Aggarwal BB 2008 Reversal of chemoresistance and enhancement of apoptosis by statins through down-regulation of the NF-kappaB pathway.
Biochem. Pharmacol. 75: 907-913.
*
-
Ahuja V, Dieckgraefe B, Anant S 2006 Molecular biology of the small intestine.
Curr. Opin. Gastroenterol. 22: 90-94.
-
Aiba S, Tagami H 1999 Dendritic cells play a crucial role in innate immunity to simple chemicals.
J. Investig. Dermatol. Symp. Proc. 4: 158-163.
*
-
Aiello A, Pandini G, Frasca F, Conte E, Murabito A, Sacco A, Genua M, Vigneri R, Belfiore A 2006 Peroxisomal proliferator-activated receptor-gamma agonists induce partial reversion of epithelial-mesenchymal transition in anaplastic thyroid cancer cells.
Endocrinology 147: 4463-4475.
*
-
Aithal GP 2007 Dangerous liaisons: drug, host and the environment.
J. Hepatol. 46: 995-998.
*
-
Ajuebor MN, Aspinall AI, Zhou F, Le T, Yang Y, Urbanski SJ, Sidobre S, Kronenberg M, Hogaboam CM, Swain MG 2005 Lack of chemokine receptor CCR5 promotes murine fulminant liver failure by preventing the apoptosis of activated CD1d-restricted NKT cells.
J. Immunol. 174: 8027-8037.
*
-
Akahori T, Sho M, Hamada K, Suzaki Y, Kuzumoto Y, Nomi T, Nakamura S, Enomoto K, Kanehiro H, Nakajima Y 2007 Importance of peroxisome proliferator-activated receptor-gamma in hepatic ischemia/reperfusion injury in mice.
J. Hepatol. 47: 784-792.
*
-
Akaishi H, Takeda K, Kaisho T, Shineha R, Satomi S, Takeda J, Akira S 1998 Defective IL-2-mediated IL-2 receptor alpha chain expression in Stat3-deficient T lymphocytes.
Int. Immunol. 10: 1747-1751.
*
-
Akare S, Jean-Louis S, Chen W, Wood DJ, Powell AA, Martinez JD 2006 Ursodeoxycholic acid modulates histone acetylation and induces differentiation and senescence.
Int. J. Cancer 119: 2958-2969.
*
-
Akbar M, Calderon F, Wen Z, Kim HY 2005 Docosahexaenoic acid: a positive modulator of Akt signaling in neuronal survival.
Proc. Natl. Acad. Sci. U.S.A. 102: 10858-10863.
*
-
Akcan A, Kucuk C, Sozuer E, Esel D, Akyildiz H, Akgun H, Muhtaroglu S, Aritas Y 2008 Melatonin reduces bacterial translocation and apoptosis in trinitrobenzene sulphonic acid-induced colitis of rats.
World J. Gastroenterol. 14: 918-924.
*
-
Akcan A, Muhtaroglu S, Akgun H, Akyildiz H, Kucuk C, Sozuer E, Yurci A, Yilmaz N 2008 Ameliorative effects of bombesin and neurotensin on trinitrobenzene sulphonic acid-induced colitis, oxidative damage and apoptosis in rats.
World J. Gastroenterol. 14: 1222-1230.
*
-
Akella R, Moon TM, Goldsmith EJ 2008 Unique MAP kinase binding sites.
Biochim. Biophys. Acta 1784: 48-55.
*
-
Akeno N, Blackard JT, Tomer Y 2008 HCV E2 protein binds directly to thyroid cells and induces IL-8 production: a new mechanism for HCV induced thyroid autoimmunity.
J. Autoimmun. Sep 15 [Epub ahead of print].
-
Aktas O, Prozorovski T, Zipp F 2006 Death ligands and autoimmune demyelination.
Neuroscientist 12: 305-316.
*
-
Aktas O, Schulze-Topphoff U, Zipp F 2007 The role of TRAIL/TRAIL receptors in central nervous system pathology.
Front. Biosci. 12: 2912-2921.
-
Al-Ashy R, Chakroun I, El-Sabban ME, Homaidan FR 2006 The role of NF-kappaB in mediating the anti-inflammatory effects of IL-10 in intestinal epithelial cells.
Cytokine 36: 1-8.
-
Al-Sadi RM, Ma TY 2007 IL-1beta causes an increase in intestinal epithelial tight junction permeability.
J. Immunol. 178: 4641-4649.
*
-
Alabraba EB, Lai V, Boon L, Wigmore SJ, Adams DH, Afford SC 2008 Coculture of human liver macrophages and cholangiocytes leads to CD40-dependent apoptosis and cytokine secretion.
Hepatology 47: 552-562.
-
Albrecht M, Domingues FS, Schreiber S, Lengauer T 2003 Identification of mammalian orthologs associates PYPAF5 with distinct functional roles.
FEBS Lett. 538: 173-177.
*
-
Albrecht M, Domingues FS, Schreiber S, Lengauer T 2003 Structural localization of disease-associated sequence variations in the NACHT and LRR domains of PYPAF1 and NOD2.
FEBS Lett. 554: 520-528.
*
-
Aldhous MC, Prescott RJ, Roberts S, Samuel K, Waterfall M, Satsangi J 2008 Does nicotine influence cytokine profile and subsequent cell cycling/apoptotic responses in inflammatory bowel disease?
Inflamm. Bowel Dis. Jul 10 [Epub ahead of print].
*
-
Aleksunes LM, Manautou JE 2007 Emerging role of Nrf2 in protecting against hepatic and gastrointestinal disease.
Toxicol. Pathol. 35: 459-473.
*
-
Aleman M, Schierloh P, De La Barrera SS, Musella RM, Saab MA, Baldini M, Abbate E, Sasiain MC 2004 Mycobacterium tuberculosis triggers apoptosis in peripheral neutrophils involving Toll-like receptor 2 and p38 mitogen protein kinase in tuberculosis patients.
Infect. Immun. 72: 5150-5158.
*
-
Alessandri C, Sorice M, Bombardieri M, Conigliaro P, Longo A, Garofalo T, Manganelli V, Conti F, Esposti ED, Valesini G 2006 Anti-phospholipid reactivity against cardiolipin metabolites occurring during endothelial cell apoptosis.
Arthritis Res. Ther. 8: R180.
*
-
Alexander JJ, Jacob A, Cunningham P, Hensley L, Quigg RJ 2008 TNF is a key mediator of septic encephalopathy acting through its receptor, TNF receptor-1.
Neurochem. Int. 52: 447-456.
-
Alexander JJ, Jacob A, Vezina P, Sekine H, Gilkeson GS, Quigg RJ 2007 Absence of functional alternative complement pathway alleviates lupus cerebritis.
Eur. J. Immunol. 37: 1691-1701.
*
-
Alghazeer R, Gao H, Howell NK 2008 Cytotoxicity of oxidised lipids in cultured colonal human intestinal cancer cells (caco-2 cells).
Toxicol. Lett. 180: 202-211.
-
Ali-Khan SE, Hales BF 2006 Retinoid receptor antagonists alter the pattern of apoptosis in organogenesis stage mouse limbs.
Toxicol. Sci. 90: 208-220.
*
-
Allgayer H, Tillmann T, Hombach A, Kruis W, Pohl C 2000 Aminosalicylates and aspirin for colonic cancer: from anti-inflammatory to antineoplastic drugs?
Z. Gastroenterol. 38: 963-970.
-
Allina J, Stanca CM, Garber J, Hu B, Sautes-Fridman C, Bach N, Odin JA 2008 Anti-CD16 autoantibodies and delayed phagocytosis of apoptotic cells in primary biliary cirrhosis.
J. Autoimmun. 30: 238-245.
-
Alpini G, Baiocchi L, Glaser S, Ueno Y, Marzioni M, Francis H, Phinizy JL, Angelico M, Lesage G 2002 Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha.
Hepatology 35: 1041-1052.
*
-
Alpini G, McGill JM, LaRusso NF 2002 The pathobiology of biliary epithelia.
Hepatology 35: 1256-1268.
*
-
Alsayed Y, Leleu X, Leontovich A, Oton AB, Melhem M, George D, Ghobrial IM 2008 Proteomics analysis in post transplant lymphoproliferative disorders (PTLD).
Eur. J. Haematol. Jun 20 [Epub ahead of print].
-
Altucci L, Gronemeyer H 2004 Retinoids and TRAIL: two cooperating actors to fight against cancer.
Vitam. Horm. 67: 319-345.
-
Altucci L, Rossin A, Hirsch O, Nebbioso A, Vitoux D, Wilhelm E, Guidez F, De Simone M, Schiavone EM, Grimwade D, Zelent A, de The H, Gronemeyer H 2005 Rexinoid-triggered differentiation and tumor-selective apoptosis of acute myeloid leukemia by protein kinase a-mediated desubordination of retinoid X receptor.
Cancer Res. 65: 8754-8765.
*
-
Alvaro D, Barbaro B, Franchitto A, Onori P, Glaser SS, Alpini G, Francis H, Marucci L, Sterpetti P, Ginanni-Corradini S, Onetti Muda A, Dostal DE, De Santis A, Attili AF, Benedetti A, Gaudio E 2006 Estrogens and insulin-like growth factor 1 modulate neoplastic cell growth in human cholangiocarcinoma.
Am. J. Pathol. 169: 877-888.
*
-
Amaral JD, Castro RE, Sola S, Steer CJ, Rodrigues CM 2007 p53 is a key molecular target of ursodeoxycholic acid in regulating apoptosis.
J. Biol. Chem. 282: 34250-34259.
*
-
Ambrosino G, Naso A, Feltracco P, Carraro P, Basso SM, Varotto S, Cillo U, Zanus 2003 Cytokines and liver failure: modification of TNF- and IL-6 in patients with acute on chronic liver decompensation treated with Molecular Adsorbent Recycling System (MARS).
Acta Biomed. Ateneo Parmense 74 Suppl. 2: 7-9.
-
Ammori JB, Zhang WZ, Li JY, Chai BX, Mulholland MW 2008 Effects of ghrelin on neuronal survival in cells derived from dorsal motor nucleus of the vagus.
Surgery 144: 159-167.
-
An Y, Xiao YB 2007 Growth hormone prevents acute liver injury induced by cardiopulmonary bypass in a rat model.
J. Thorac. Cardiovasc. Surg. 134: 342-350.
-
Anan A, Baskin-Bey ES, Bronk SF, Werneburg NW, Shah VH, Gores GJ 2006 Proteasome inhibition induces hepatic stellate cell apoptosis.
Hepatology 43: 335-344.
*
-
Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, Aggarwal BB 2008 Curcumin and cancer: an "old-age" disease with an "age-old" solution.
Cancer Lett. 267: 133-164.
*
-
Andersen J, Vanscoy S, Cheng TF, Gomez D, Reich NC 2008 IRF-3-dependent and augmented target genes during viral infection.
Genes Immun. 9: 168-175.
*
-
Anderson CD, Pierce J, Nicoud I, Belous A, Knox CD, Chari RS 2005 Modulation of mitochondrial calcium management attenuates hepatic warm ischemia-reperfusion injury.
Liver Transpl. 11: 663-668.
*
-
Anderson MK 2006 At the crossroads: diverse roles of early thymocyte transcriptional regulators.
Immunol. Rev. 209: 191-211.
-
Andersson U, Tracey KJ 2004 HMGB1 as a mediator of necrosis-induced inflammation and a therapeutic target in arthritis.
Rheum. Dis. Clin. North Am. 30: 627-637, xi.
-
Andoh A, Tsujikawa T, Fujiyama Y 2003 Role of dietary fiber and short-chain fatty acids in the colon.
Curr. Pharm. Des. 9: 347-358.
-
Andre J, Cimaz R, Ranchin B, Galambrun C, Bertrand Y, Bouvier R, Rieux-Laucat F, Trescol-Biemont MC, Cochat P, Bonnefoy-Berard N 2007 Overexpression of the antiapoptotic gene Bfl-1 in B cells from patients with familial systemic lupus erythematosus.
Lupus 16: 95-100.
-
Anel A, Bosque A, Naval J, Pineiro A, Larrad L, Alava MA, Martinez-Lorenzo MJ 2007 Apo2L/TRAIL and immune regulation.
Front. Biosci. 12: 2074-2084.
-
Angulo P 2002 Use of ursodeoxycholic acid in patients with liver disease.
Curr. Gastroenterol. Rep. 4: 37-44.
-
Anlar B, Senbil N, Guven A 2007 Doxycycline in autoimmune central nervous system disorders in children: an in vitro study.
Turk. J. Pediatr. 49: 274-277.
-
Annereau JP, Szakacs G, Tucker CJ, Arciello A, Cardarelli C, Collins J, Grissom S, Zeeberg B, Reinhold W, Weinstein J, Pommier Y, Paules RS, Gottesman MM 2004 Analysis of ATP-binding cassette transporter expression in drug-selected cell lines by a microarray dedicated to multidrug resistance.
Mol. Pharmacol. 66: 1397-1405.
*
-
Ansari AA 2004 Autoimmunity, anergy, lentiviral immunity and disease.
Autoimmun. Rev. 3: 530-540.
-
Anthoni M, Fyhrquist-Vanni N, Wolff H, Alenius H, Lauerma A 2008 Transforming growth factor-beta/Smad3 signalling regulates inflammatory responses in a murine model of contact hypersensitivity.
Br. J. Dermatol. Jun 27 [Epub ahead of print].
*
-
Aoki CA, Borchers AT, Li M, Flavell RA, Bowlus CL, Ansari AA, Gershwin ME 2005 Transforming growth factor beta (TGF-beta) and autoimmunity.
Autoimmun. Rev. 4: 450-459.
-
Aoki CA, Borchers AT, Ridgway WM, Keen CL, Ansari AA, Gershwin ME 2005 NOD mice and autoimmunity.
Autoimmun. Rev. 4: 373-379.
-
Arafat HA, Lada E, Katakam AK, Amin N 2006 Osteopontin deficiency impacts the pancreatic TH1/TH2 cytokine profile following multiple low dose streptozotocin-induced diabetes.
Exp. Clin. Endocrinol. Diabetes 114: 555-562.
-
Aram G, Potter JJ, Liu X, Torbenson MS, Mezey E 2008 Lack of inducible nitric oxide synthase leads to increased hepatic apoptosis and decreased fibrosis in mice after chronic carbon tetrachloride administration.
Hepatology 47: 2051-2058.
-
Aravalli RN, Hu S, Lokensgard JR 2007 Toll-like receptor 2 signaling is a mediator of apoptosis in herpes simplex virus-infected microglia.
J. Neuroinflammation 4: 11.
-
Arber N, DuBois RN 1999 Nonsteroidal anti-inflammatory drugs and prevention of colorectal cancer.
Curr. Gastroenterol. Rep. 1: 441-448.
-
Arcila ML, Sanchez MD, Ortiz B, Barrera LF, Garcia LF, Rojas M 2007 Activation of apoptosis, but not necrosis, during Mycobacterium tuberculosis infection correlated with decreased bacterial growth: role of TNF-alpha, IL-10, caspases and phospholipase A2.
Cell. Immunol. 249: 80-93.
-
Argast GM, Campbell JS, Brooling JT, Fausto N 2004 Epidermal growth factor receptor transactivation mediates tumor necrosis factor-induced hepatocyte replication.
J. Biol. Chem. 279: 34530-34536.
*
-
Arias CF, Ballesteros-Tato A, Garcia MI, Martin-Caballero J, Flores JM, Martinez-A C, Balomenos D 2007 p21CIP1/WAF1 controls proliferation of activated/memory T cells and affects homeostasis and memory T cell responses.
J. Immunol. 178: 2296-2306.
*
-
Ariel A, Li PL, Wang W, Tang WX, Fredman G, Hong S, Gotlinger KH, Serhan CN 2005 The docosatriene protectin D1 is produced by TH2-skewing and promotes human T cell apoptosis via lipid-raft clustering.
J. Biol. Chem. 280: 43079-43086.
*
-
Arii K, Kumon Y, Sugahara K, Nakatani K, Ikeda Y, Suehiro T, Hashimoto K 2008 Edaravone inhibits collagen-induced arthritis possibly through suppression of nuclear factor-kappa B.
Mol. Immunol. 45: 463-469.
*
-
Arimilli S, Johnson JB, Alexander-Miller MA, Parks GD 2007 TLR-4 and -6 agonists reverse apoptosis and promote maturation of simian virus 5-infected human dendritic cells through NFkB-dependent pathways.
Virology 365: 144-156.
*
-
Aromataris EC, Castro J, Rychkov GY, Barritt GJ 2008 Store-operated Ca(2+) channels and stromal interaction molecule 1 (STIM1) are targets for the actions of bile acids on liver cells.
Biochim. Biophys. Acta 1783: 874-885.
*
-
Arredondo J, Chernyavsky AI, Jolkovsky DL, Webber RJ, Grando SA 2006 SLURP-2: a novel cholinergic signaling peptide in human mucocutaneous epithelium.
J. Cell. Physiol. 208: 238-245.
*
-
Arthur AT, Armati PJ, Bye C, Consortium SM, Heard RN, Stewart GJ, Pollard JD, Booth DR 2008 Genes implicated in multiple sclerosis pathogenesis from consilience of genotyping and expression profiles in relapse and remission.
BMC Med. Genet. 9: 17.
*
-
Artwohl M, Lindenmair A, Sexl V, Maier C, Rainer G, Freudenthaler A, Huttary N, Wolzt M, Nowotny P, Luger A, Baumgartner-Parzer SM 2008 Different mechanisms of saturated versus polyunsaturated free fatty acid-induced apoptosis in human endothelial cells.
J. Lipid Res. Aug 5 [Epub ahead of print].
*
-
Aruna BV, Ben-David H, Sela M, Mozes E 2006 A dual altered peptide ligand down-regulates myasthenogenic T cell responses and reverses experimental autoimmune myasthenia gravis via up-regulation of Fas-FasL-mediated apoptosis.
Immunology 118: 413-424.
*
-
Arya R, Mallik M, Lakhotia SC 2007 Heat shock genes - integrating cell survival and death.
J. Biosci. 32: 595-610.
*
-
Asakura H, Suzuki A, Ohtsuka K, Hasegawa K, Sugimura K 1999 Gut-associated lymphoid tissues in ulcerative colitis.
JPEN J. Parenter. Enteral Nutr. 23: S25-S28.
-
Ashikawa K, Shishodia S, Fokt I, Priebe W, Aggarwal BB 2004 Evidence that activation of nuclear factor-kappaB is essential for the cytotoxic effects of doxorubicin and its analogues.
Biochem. Pharmacol. 67: 353-364.
*
-
Ashwell JD 2008 TWEAKing death.
J. Cell. Biol. 182: 15-17.
*
-
Ashwell JD, Lu FW, Vacchio MS 2000 Glucocorticoids in T cell development and function.
Annu. Rev. Immunol. 18: 309-345.
*
-
Asquith DL, McInnes IB 2007 Emerging cytokine targets in rheumatoid arthritis.
Curr. Opin. Rheumatol. 19: 246-251.
-
Assi K, Pillai R, Gomez-Munoz A, Owen D, Salh B 2006 The specific JNK inhibitor SP600125 targets tumour necrosis factor-alpha production and epithelial cell apoptosis in acute murine colitis.
Immunology 118: 112-121.
*
-
Assimakopoulos SF, Scopa CD, Vagianos CE 2007 Pathophysiology of increased intestinal permeability in obstructive jaundice.
World J. Gastroenterol. 13: 6458-6464.
*
-
Ates A, Kinikli G, Turgay M, Duman M 2004 The levels of serum-soluble Fas in patients with rheumatoid arthritis and systemic sclerosis.
Clin. Rheumatol. 23: 421-425.
*
-
Atreya R, Atreya I, Neurath MF 2006 Novel signal transduction pathways: analysis of STAT-3 and Rac-1 signaling in inflammatory bowel disease.
Ann. N. Y. Acad. Sci. 1072: 98-113.
*
-
Atreya R, Mudter J, Finotto S, Mullberg J, Jostock T, Wirtz S, Schutz M, Bartsch B, Holtmann M, Becker C, Strand D, Czaja J, Schlaak JF, Lehr HA, Autschbach F, Schurmann G, Nishimoto N, Yoshizaki K, Ito H, Kishimoto T, Galle PR, Rose-John S, Neurath MF 2000 Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn disease and experimental colitis in vivo.
Nat. Med. 6: 583-588.
*
-
Atreya R, Neurath MF 2005 Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer.
Clin. Rev. Allergy Immunol. 28: 187-196.
-
Atreya R, Neurath MF 2008 New therapeutic strategies for treatment of inflammatory bowel disease.
Mucosal Immunol. 1: 175-182. *
-
Augstein P, Heinke P, Salzsieder E, Grimm R, Giebel J, Salzsieder C, Harrison LC 2008 Dominance of cytokine- over FasL-induced impairment of the mitochondrial transmembrane potential (Deltapsim) in the pancreatic beta-cell line NIT-1.
Diab. Vasc. Dis. Res. 5: 198-204.
-
Aune TM, Maas K, Moore JH, Olsen NJ 2003 Gene expression profiles in human autoimmune disease.
Curr. Pharm. Des. 9: 1905-1917.
-
Auricchio L, Vitiello L, Adriani M, Ferri P, Chiocchetti A, Pettinato G, Racioppi L, Maiuri L, Dianzani U, Pignata C 2005 Cutaneous manifestations as presenting sign of autoimmune lymphoproliferative syndrome in childhood.
Dermatology 210: 336-340.
-
Averbeck M, Gebhardt C, Emmrich F, Treudler R, Simon JC 2007 Immunologic principles of allergic disease.
J. Dtsch. Dermatol. Ges. 5: 1015-1028.
-
Axtell RC, Xu L, Barnum SR, Raman C 2006 CD5-CK2 binding/activation-deficient mice are resistant to experimental autoimmune encephalomyelitis: protection is associated with diminished populations of IL-17-expressing T cells in the central nervous system.
J. Immunol. 177: 8542-8549.
*
-
Ayensu WK, Tchounwou PB 2006 Microarray analysis of mercury-induced changes in gene expression in human liver carcinoma (HepG2) cells: importance in immune responses.
Int. J. Environ. Res. Public Health 3: 141-173.
-
Ayensu WK, Tchounwou PB, McMurray RW 2004 Molecular and cellular mechanisms associated with autoimmune diseases.
Int. J. Environ. Res. Public Health 1: 39-73.
-
Azkargorta M, Arizmendi JM, Elortza F, Alkorta N, Zubiaga AM, Fullaondo A 2006 Differential proteome profiles in E2F2-deficient T lymphocytes.
Proteomics 6 Suppl. 1: S42-S50.
*
-
Azulay-Debby H, Edry E, Melamed D 2007 CpG DNA stimulates autoreactive immature B cells in the bone marrow.
Eur. J. Immunol. 37: 1463-1475.
*
-
Azzaroli F, Mehal W, Soroka CJ, Wang L, Lee J, Crispe N, Boyer JL 2002 Ursodeoxycholic acid diminishes Fas-ligand-induced apoptosis in mouse hepatocytes.
Hepatology 36: 49-54.
*
-
Baba N, Kobashi H, Yamamoto K, Terada R, Suzuki T, Hakoda T, Okano N, Shimada N, Fujioka S, Iwasaki Y, Shiratori Y 2006 Gene expression profiling in biliary epithelial cells of primary biliary cirrhosis using laser capture microdissection and cDNA microarray.
Transl. Res. 148: 103-113.
*
-
Bach JF, Koutouzov S, van Endert PM 1998 Are there unique autoantigens triggering autoimmune diseases?
Immunol. Rev. 164: 139-155.
-
Backlund MG, Mann JR, Holla VR, Buchanan FG, Tai HH, Musiek ES, Milne GL,Katkuri S, Dubois RN 2005 15-Hydroxyprostaglandin dehydrogenase is downregulated in colorectal cancer.
J. Biol. Chem. 280: 3217-3223.
*
-
Bae SC, Choi JK 2004 Tumor suppressor activity of RUNX3.
Oncogene 23: 4336-4340.
*
-
Bagnall RD, Roberts RG, Mirza MM, Torigoe T, Prescott NJ, Mathew CG 2008 Novel isoforms of the CARD8 (TUCAN) gene evade a nonsense mutation.
Eur. J. Hum. Genet. 16: 619-625.
*
-
Bai A, Hu P, Chen J, Song X, Chen W, Peng W, Zeng Z, Gao X 2007 Blockade of STAT3 by antisense oligonucleotide in TNBS-induced murine colitis.
Int. J. Colorectal Dis. 22: 625-635.
*
-
Bai J, Odin JA 2003 Apoptosis and the liver: relation to autoimmunity and related conditions.
Autoimmun. Rev. 2: 36-42.
*
-
Bai L, Kao JY, Law DJ, Merchant JL 2006 Recruitment of ataxia-telangiectasia mutated to the p21(waf1) promoter by ZBP-89 plays a role in mucosal protection.
Gastroenterology 131: 841-852.
*
-
Bajt ML, Ho YS, Vonderfecht SL, Jaeschke H 2002 Reactive oxygen as modulator of TNF and Fas receptor-mediated apoptosis in vivo: studies with glutathione peroxidase-deficient mice.
Antioxid. Redox Signal. 4: 733-740.
-
Balabanov R, Strand K, Goswami R, McMahon E, Begolka W, Miller SD, Popko B 2007 Interferon-gamma-oligodendrocyte interactions in the regulation of experimental autoimmune encephalomyelitis.
J. Neurosci. 27: 2013-2024.
*
-
Balabanov R, Strand K, Kemper A, Lee JY, Popko B 2006 Suppressor of cytokine signaling 1 expression protects oligodendrocytes from the deleterious effects of interferon-gamma.
J. Neurosci. 26: 5143-5152.
-
Baldassarre ME, Altomare MA, Fanelli M, Carbone D, Di Bitonto G, Mautone A, Laforgia N 2007 Does calprotectin represent a regulatory factor in host defense or a drug target in inflammatory disease?
Endocr. Metab. Immune Disord. Drug Targets 7: 1-5.
-
Balistreri WF 2003 Genetic liver disease.
54th Annual Meeting of the American Association for the Study of Liver Diseases.
-
Balistreri WF 1997 Bile acid therapy in pediatric hepatobiliary disease: the role of ursodeoxycholic acid.
J. Pediatr. Gastroenterol. Nutr. 24: 573-589.
-
Ballestero MR, Monte MJ, Briz O, Jimenez F, Gonzalez-San Martin F, Marin JJ 2006 Expression of transporters potentially involved in the targeting of cytostatic bile acid derivatives to colon cancer and polyps.
Biochem. Pharmacol. 72: 729-738.
*
-
Balog A, Klausz G, Gal J, Molnar T, Nagy F, Ocsovszky I, Gyulai Z, Mandi Y 2004 Investigation of the prognostic value of TNF-alpha gene polymorphism among patients treated with infliximab, and the effects of infliximab therapy on TNF-alpha production and apoptosis.
Pathobiology 71: 274-280.
-
Ban JO, Hwang IG, Kim TM, Hwang BY, Lee US, Jeong HS, Yoon YW, Kimz DJ, Hong JT 2007 Anti-proliferate and pro-apoptotic effects of 2,3-dihydro-3,5-dihydroxy-6-methyl-4H-pyranone through inactivation of NF-kappaB in human colon cancer cells.
Arch. Pharm. Res. 30: 1455-1463.
-
Ban L, Zhang J, Wang L, Kuhtreiber W, Burger D, Faustman DL 2008 Selective death of autoreactive T cells in human diabetes by TNF or TNF receptor 2 agonism.
Proc. Natl. Acad. Sci. U.S.A. 105: 13644-13649.
*
-
Bancroft LK, Lupton JR, Davidson LA, Taddeo SS, Murphy ME, Carroll RJ, Chapkin RS 2003 Dietary fish oil reduces oxidative DNA damage in rat colonocytes.
Free Radic. Biol. Med. 35: 149-159.
-
Banerjee M, Huang C, Marquez J, Mohanty S 2008 Probing the structure and function of human glutaminase-interacting protein: a possible target for drug design.
Biochemistry 47: 9208-9219.
*
-
Bangs SC, McMichael AJ, Xu XN 2006 Bystander T cell activation - implications for HIV infection and other diseases.
Trends Immunol. 27: 518-524.
*
-
Bankar RN, Dafe CO, Kohnke A, Babu PS 2006 Ulcerative colitis probably associated with isotretinoin.
Indian J. Gastroenterol. 25: 171-172.
*
-
Bannerman DD, Eiting KT, Winn RK, Harlan JM 2004 FLICE-like inhibitory protein (FLIP) protects against apoptosis and suppresses NF-kappaB activation induced by bacterial lipopolysaccharide.
Am. J. Pathol. 165: 1423-1431.
*
-
Banno T, Gazel A, Blumenberg M 2005 Pathway-specific profiling identifies the NFkB-dependent TNFa-regulated genes in epidermal keratinocytes.
J. Biol. Chem. 280: 18973-18980.
*
-
Banno T, Gazel A, Blumenberg M 2004 Effects of tumor necrosis factor-alpha (TNFalpha) in epidermal keratinocytes revealed using global transcriptional profiling.
J. Biol. Chem. 279: 32633-32642.
*
-
Bansal MB, Kovalovich K, Gupta R, Li W, Agarwal A, Radbill B, Alvarez CE, Safadi R, Fiel MI, Friedman SL, Taub RA 2005 Interleukin-6 protects hepatocytes from CCl4-mediated necrosis and apoptosis in mice by reducing MMP-2 expression.
J. Hepatol. 42: 548-556.
*
-
Bantel H, Lugering A, Heidemann J, Volkmann X, Poremba C, Strassburg CP, Manns MP, Schulze-Osthoff K 2004 Detection of apoptotic caspase activation in sera from patients with chronic HCV infection is associated with fibrotic liver injury.
Hepatology 40: 1078-1087.
*
-
Banus S, Pennings J, Vandebriel R, Wester P, Breit T, Mooi F, Hoebee B, Kimman T 2007 Lung response to Bordetella pertussis infection in mice identified by gene-expression profiling.
Immunogenetics 59: 555-564.
*
-
Bao C, Guo J, Lin G, Hu M, Hu Z 2008 TNFR gene-modified mesenchymal stem cells attenuate inflammation and cardiac dysfunction following MI.
Scand. Cardiovasc. J. 42: 56-62.
-
Bao L, Osawe I, Puri T, Lambris JD, Haas M, Quigg RJ 2005 C5a promotes development of experimental lupus nephritis which can be blocked with a specific receptor antagonist.
Eur. J. Immunol. 35: 2496-2506.
*
-
Baradari V, Hopfner M, Huether A, Schuppan D, Scherubl H 2007 Histone deacetylase inhibitor MS-275 alone or combined with bortezomib or sorafenib exhibits strong antiproliferative action in human cholangiocarcinoma cells.
World J. Gastroenterol. 13: 4458-4466.
*
-
Barancik M, Bohacova V, Sedlak J, Sulova Z, Breier A 2006 LY294,002, a specific inhibitor of PI3K/Akt kinase pathway, antagonizes P-glycoprotein-mediated multidrug resistance.
Eur. J. Pharm. Sci. 29: 426-434.
*
-
Baranda L, de la Fuente H, Layseca-Espinosa E, Portales-Perez D, Nino-Moreno P, Valencia-Pacheco G, Abud-Mendoza C, Alcocer-Varela J, Gonzalez-Amaro R 2005 IL-15 and IL-15R in leucocytes from patients with systemic lupus erythematosus.
Rheumatology (Oxford) 44: 1507-1513.
*
-
Baranova A 2008 PPAR ligands as potential modifiers of breast carcinoma outcomes.
PPAR Res. 2008: 230893.
*
-
Barbeau WE, Bassaganya-Riera J, Hontecillas R 2007 Putting the pieces of the puzzle together - a series of hypotheses on the etiology and pathogenesis of type 1 diabetes.
Med. Hypotheses 68: 607-619.
-
Bardaro T, Falco G, Sparago A, Mercadante V, Gean Molins E, Tarantino E, Ursini MV, D'Urso M 2003 Two cases of misinterpretation of molecular results in incontinentia pigmenti, and a PCR-based method to discriminate NEMO/IKKgamma dene deletion.
Hum. Mutat. 21: 8-11.
-
Barisic S, Strozyk E, Peters N, Walczak H, Kulms D 2008 Identification of PP2A as a crucial regulator of the NF-kappaB feedback loop: its inhibition by UVB turns NF-kappaB into a pro-apoptotic factor.
Cell Death Differ. Jun 27 [Epub ahead of print].
*
-
Barland P 2004 Antibodies to citrullinated peptides: current role in diagnosis, prognosis, and pathogenesis of rheumatoid arthritis.
New Developments in Rheumatic Diseases 1: 6-9. *
-
Barnett MH, Sutton I 2006 The pathology of multiple sclerosis: a paradigm shift.
Curr. Opin. Neurol. 19: 242-247.
-
Barnich N, Aguirre JE, Reinecker HC, Xavier R, Podolsky DK 2005 Membrane recruitment of NOD2 in intestinal epithelial cells is essential for nuclear factor-kappaB activation in muramyl dipeptide recognition.
J. Cell. Biol. 170: 21-26.
*
-
Barone MV, Gimigliano A, Castoria G, Paolella G, Maurano F, Paparo F, Maria M, Nanayakkara M, Mineo A, Miele E, Troncone R, Auricchio S 2007 Growth factor-like activity of gliadin, an alimentary protein: implications for coeliac disease.
Gut 56: 480-488.
*
-
Barone MV, Caputo I, Ribecco MT, Maglio M, Marzari R, Sblattero D, Troncone R, Auricchio S, Esposito C 2007 Humoral immune response to tissue transglutaminase is related to epithelial cell proliferation in celiac disease.
Gastroenterology 132: 1245-1253.
*
-
Baroni E, Biffi M, Benigni F, Monno A, Carlucci D, Carmeliet G, Bouillon R, D'Ambrosio D 2007 VDR-dependent regulation of mast cell maturation mediated by 1,25-dihydroxyvitamin D3.
J. Leukoc. Biol. 81: 250-262.
*
-
Barrera G, Toaldo C, Pizzimenti S, Cerbone A, Pettazzoni P, Dianzani MU, Ferretti C 2008 The role of PPAR ligands in controlling growth-related gene expression and their interaction with lipoperoxidation products.
PPAR Res. 2008: 524671.
*
-
Bartels LE, Jorgensen SP, Agnholt J, Kelsen J, Hvas CL, Dahlerup JF 2007 1,25-Dihydroxyvitamin D3 and dexamethasone increase interleukin-10 production in CD4+ T cells from patients with Crohn's disease.
Int. Immunopharmacol. 7: 1755-1764.
-
Bartl T, Zadnikova P, Jirikovska R, Marouskova B, Benes L 2008 Substances modifying the activity of caspases.
Ceska. Slov. Farm. 57: 29-34.
-
Bartolini G, Orlandi M, Papi A, Ammar K, Guerra F, Ferreri AM, Rocchi P 2006 A search for multidrug resistance modulators: the effects of retinoids in human colon carcinoma cells.
In Vivo 20: 729-733.
-
Barton BE 2006 STAT3: a potential therapeutic target in dendritic cells for the induction of transplant tolerance.
Expert Opin. Ther. Targets 10: 459-470.
-
Barzilai O, Ram M, Shoenfeld Y 2007 Viral infection can induce the production of autoantibodies.
Curr. Opin. Rheumatol. 19: 636-643.
-
Bascones-Ilundain C, Gonzalez-Moles MA, Esparza-Gomez G, Gil-Montoya JA, Bascones-Martinez A 2006 Importance of apoptotic mechanisms in inflammatory infiltrate of oral lichen planus lesions.
Anticancer Res. 26: 357-362.
-
Baskin-Bey ES, Anan A, Isomoto H, Bronk SF, Gores GJ 2007 Constitutive androstane receptor agonist, TCPOBOP, attenuates steatohepatitis in the methionine choline-deficient diet-fed mouse.
World J. Gastroenterol. 13: 5635-5641.
*
-
Baskin-Bey ES, Huang W, Ishimura N, Isomoto H, Bronk SF, Braley K, Craig RW, Moore DD, Gores GJ 2006 Constitutive androstane receptor (CAR) ligand, TCPOBOP, attenuates Fas-induced murine liver injury by altering Bcl-2 proteins.
Hepatology 44: 252-262.
*
-
Baslund B, Tvede N, Danneskiold-Samsoe B, Larsson P, Panayi G, Petersen J, Petersen LJ, Beurskens FJ, Schuurman J, van de Winkel JG, Parren PW, Gracie JA, Jongbloed S, Liew FY, McInnes IB 2005 Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept study.
Arthritis Rheum. 52: 2686-2692.
*
-
Bason C, Corrocher R, Lunardi C, Puccetti P, Olivieri O, Girelli D, Navone R, Beri R, Millo E, Margonato A, Martinelli N, Puccetti A 2003 Interaction of antibodies against cytomegalovirus with heat-shock protein 60 in pathogenesis of atherosclerosis.
Lancet 362: 1971-1977.
*
-
Bassendine MF 2004 Infectious etiology of primary biliary cirrhosis (PBC).
Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, pp. 45-46. *
-
Basset C, Holton J, Gatta L, Ricci C, Bernabucci V, Liuzzi G, Vaira D 2004 Helicobacter pylori infection: anything new should we know?
Aliment. Pharmacol. Ther. 20 Suppl. 2: 31-41.
-
Basu S, Pathak SK, Banerjee A, Pathak S, Bhattacharyya A, Yang Z, Talarico S, Kundu M, Basu J 2007 Execution of macrophage apoptosis by PE_PGRS33 of Mycobacterium tuberculosis is mediated by Toll-like receptor 2-dependent release of tumor necrosis factor-alpha.
J. Biol. Chem. 282: 1039-1050.
*
-
Bataller R, Brenner DA 2001 Hepatic stellate cells as a target for the treatment of liver fibrosis.
Semin. Liver Dis. 21: 437-451.
-
Batbayar B, Nagy G, Kovesi G, Zelles T, Feher E 2004 Morphological basis of sensory neuropathy and neuroimmunomodulation in minor salivary glands of patients with Sjogren's syndrome.
Arch. Oral Biol. 49: 529-538.
-
Batinac T, Zamolo G, Hadzisejdic I, Zauhar G, Brumini G, Ruzic A, Persic V 2007 Expression of Bcl-2 family proteins in psoriasis.
Croat. Med. J. 48: 319-326.
*
-
Battelli MG, Musiani S, Tazzari PL, Stirpe F 2001 Oxidative stress to human lymphocytes by xanthine oxidoreductase activity.
Free Radic. Res. 35: 665-679.
-
Bauer J, Elger CE, Hans VH, Schramm J, Urbach H, Lassmann H, Bien CG 2007 Astrocytes are a specific immunological target in Rasmussen's encephalitis.
Ann. Neurol. 62: 67-80.
-
Bauer M, Hamm AC, Bonaus M, Jacob A, Jaekel J, Schorle H, Pankratz MJ, Katzenberger JD 2004 Starvation response in mouse liver shows strong correlation with life-span-prolonging processes.
Physiol. Genomics 17: 230-244.
*
-
Bauer S, Abdgawad M, Gunnarsson L, Segelmark M, Tapper H, Hellmark T 2007 Proteinase 3 and CD177 are expressed on the plasma membrane of the same subset of neutrophils.
J. Leukoc. Biol. 81: 458-464.
*
-
Baumgardner JN, Shankar K, Korourian S, Badger TM, Ronis MJ 2007 Undernutrition enhances alcohol-induced hepatocyte proliferation in the liver of rats fed via total enteral nutrition.
Am. J. Physiol. Gastrointest. Liver Physiol. 293: G355-G364.
*
-
Baus-Loncar M, Lubka M, Pusch CM, Otto WR, Poulsom R, Blin N 2007 Cytokine regulation of the trefoil factor family binding protein GKN2 (GDDR/TFIZ1/blottin) in human gastrointestinal epithelial cells.
Cell. Physiol. Biochem. 20: 193-204.
-
Bayat A, Walter J, Lambe H, Watson JS, Stanley JK, Marino M, Ferguson MW, Ollier WE 2005 Identification of a novel mitochondrial mutation in Dupuytren's disease using multiplex DHPLC.
Plast. Reconstr. Surg. 115: 134-141.
-
Bayry J, Lacroix-Desmazes S, Kazatchkine MD, Kaveri SV 2007 Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: rationale and mechanisms of action.
Nat. Clin. Pract. Rheumatol. 3: 262-272.
*
-
Bazan NG 2006 Cell survival matters: docosahexaenoic acid signaling, neuroprotection and photoreceptors.
Trends Neurosci. 29: 263-271.
*
-
Bazan NG 2008 Neurotrophins induce neuroprotective signaling in the retinal pigment epithelial cell by activating the synthesis of the anti-inflammatory and anti-apoptotic neuroprotectin D1.
Adv. Exp. Med. Biol. 613: 39-44.
-
Becker S, Reinehr R, Graf D, Vom Dahl S, Haussinger D 2007 Hydrophobic bile salts induce hepatocyte shrinkage via NADPH oxidase activation.
Cell. Physiol. Biochem. 19: 89-98.
-
Bedini C, Nasorri F, Girolomoni G, Pita OD, Cavani A 2007 Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function.
Br. J. Dermatol. 157: 249-258.
*
-
Beer TM, Myrthue A 2006 Calcitriol in the treatment of prostate cancer.
Anticancer Res. 26: 2647-2651.
-
Begue B, Wajant H, Bambou JC, Dubuquoy L, Siegmund D, Beaulieu JF, Canioni D, Berrebi D, Brousse N, Desreumaux P, Schmitz J, Lentze MJ, Goulet O, Cerf-Bensussan N, Ruemmele FM 2006 Implication of TNF-related apoptosis-inducing ligand in inflammatory intestinal epithelial lesions.
Gastroenterology 130: 1962-1974.
*
-
Behrens EM, Ning Y, Muvarak N, Zoltick PW, Flake AW, Gallucci S 2008 Apoptotic cell-mediated immunoregulation of dendritic cells does not require iC3b opsonization.
J. Immunol. 181: 3018-3026.
-
Bel Hadj Jrad B, Mahfouth W, Bouaouina N, Gabbouj S, Ahmed SB, Ltaief M, Jalbout M, Chouchane L 2006 A polymorphism in FAS gene promoter associated with increased risk of nasopharyngeal carcinoma and correlated with anti-nuclear autoantibodies induction.
Cancer Lett. 233: 21-27.
*
-
Belitsky GA, Yakubovskaya MG 2008 Genetic polymorphism and variability of chemical carcinogenesis.
Biochemistry (Mosc.) 73: 543-554.
-
Bell CW, Jiang W, Reich CF 3rd, Pisetsky DS 2006 The extracellular release of HMGB1 during apoptotic cell death.
Am. J. Physiol. Cell Physiol. 291: C1318-C1325.
*
-
Ben-Ari Z, Schmilovotz-Weiss H, Belinki A, Pappo O, Sulkes J, Neuman MG, Kaganovsky E, Kfir B, Tur-Kaspa R, Klein T 2003 Circulating soluble cytochrome c in liver disease as a marker of apoptosis.
J. Intern. Med. 254: 168-175.
*
-
Benais-Pont G, Dupertuis YM, Kossovsky MP, Nouet P, Allal AS, Buchegger F, Pichard C 2006 omega-3 Polyunsaturated fatty acids and ionizing radiation: combined cytotoxicity on human colorectal adenocarcinoma cells.
Nutrition 22: 931-939.
*
-
Bengmark S, Gil A 2006 Bioecological and nutritional control of disease: prebiotics, probiotics and synbiotics.
Nutr. Hosp. 21 Suppl. 2: 72-84, 73-86.
-
Benoit M, Fenollar F, Raoult D, Mege JL 2007 Increased levels of circulating IL-16 and apoptosis markers are related to the activity of Whipple's disease.
PLoS ONE 2: e494.
*
-
Benseler V, McCaughan GW, Schlitt HJ, Bishop GA, Bowen DG, Bertolino P 2007 The liver: a special case in transplantation tolerance.
Semin. Liver Dis. 27: 194-213.
-
Benson M, Carlsson L, Guillot G, Jernas M, Langston MA, Rudemo M, Andersson B 2006 A network-based analysis of allergen-challenged CD4+ T cells from patients with allergic rhinitis.
Genes Immun. 7: 514-521.
*
-
Benz C, Angermuller S, Kloters-Plachky P, Sauer P, Stremmel W, Stiehl A 1998 Effect of S-adenosylmethionine versus tauroursodeoxycholic acid on bile acid-induced apoptosis and cytolysis in rat hepatocytes.
Eur. J. Clin. Invest. 28: 577-583.
-
Benz C, Angermuller S, Otto G, Sauer P, Stremmel W, Stiehl A 2000 Effect of tauroursodeoxycholic acid on bile acid-induced apoptosis in primary human hepatocytes.
Eur. J. Clin. Invest. 30: 203-209.
-
Benz C, Angermuller S, Tox U, Kloters-Plachky P, Riedel HD, Sauer P, Stremmel W, Stiehl A 1998 Effect of tauroursodeoxycholic acid on bile-acid-induced apoptosis and cytolysis in rat hepatocytes.
J. Hepatol. 28: 99-106.
*
-
Beraza N, Ludde T, Assmus U, Roskams T, Borght SV, Trautwein C 2007 Hepatocyte-specific IKKgamma/NEMO expression determines the degree of liver injury.
Gastroenterology 132: 2504-2517.
*
-
Beraza N, Malato Y, Vander Borght S, Liedtke C, Wasmuth HE, Dreano M, de Vos R, Roskams T, Trautwein C 2008 Pharmacological IKK2 inhibition blocks liver steatosis and initiation of non-alcoholic steatohepatitis.
Gut 57: 655-663.
-
Beraza N, Marques JM, Martinez-Anso E, Iniguez M, Prieto J, Bustos M 2005 Interplay among cardiotrophin-1, prostaglandins, and vascular endothelial growth factor in rat liver regeneration.
Hepatology 41: 460-469.
*
-
Berdowska I 2004 Cysteine proteases as disease markers.
Clin. Chim. Acta 342: 41-69.
*
-
Berg CP, Stein GM, Keppeler H, Gregor M, Wesselborg S, Lauber K 2008 Apoptosis-associated antigens recognized by autoantibodies in patients with the autoimmune liver disease primary biliary cirrhosis.
Apoptosis 13: 63-75.
-
Bergamo P, Luongo D, Maurano F, Mazzarella G, Stefanile R, Rossi M 2006 Conjugated linoleic acid enhances glutathione synthesis and attenuates pathological signs in MRL/lpr mice.
J. Lipid Res. 47: 2382-2391.
*
-
Bergasa NV, Mason A, Floreani A, Heathcote J, Swain MG, Jones DE, Lindor KM, Bassendine MF, Worman HJ 2004 Primary biliary cirrhosis: report of a focus study group.
Hepatology 40: 1013-1020.
*
-
Berger A, Roberts MA, Hoff B 2006 How dietary arachidonic- and docosahexaenoic- acid rich oils differentially affect the murine hepatic transcriptome.
Lipids Health Dis. 5: 10.
*
-
Bergholdt R, Karlsen AE, Hagedorn PH, Aalund M, Nielsen JH, Kruhoffer M, Orntoft T, Wang H, Wollheim CB, Nerup J, Pociot F 2007 Transcriptional profiling of type 1 diabetes genes on chromosome 21 in a rat beta-cell line and human pancreatic islets.
Genes Immun. 8: 232-238.
*
-
Bergman ML, Cilio CM, Penha-Goncalves C, Lamhamedi-Cherradi SE, Lofgren A, Colucci F, Lejon K, Garchon HJ, Holmberg D 2001 CTLA-4-/- mice display T cell-apoptosis resistance resembling that ascribed to autoimmune-prone non-obese diabetic (NOD) mice.
J. Autoimmun. 16: 105-113.
-
Bergman MP, Vandenbroucke-Grauls CM, Appelmelk BJ, D'Elios MM, Amedei A, Azzurri A, Benagiano M, Del Prete G 2005 The story so far: Helicobacter pylori and gastric autoimmunity.
Int. Rev. Immunol. 24: 63-91.
-
Bergquist A, Glaumann H, Stal P, Wang GS, Broome U 2001 Biliary dysplasia, cell proliferation and nuclear DNA-fragmentation in primary sclerosing cholangitis with and without cholangiocarcinoma.
J. Intern. Med. 249: 69-75.
*
-
Berlin AL, Paller AS, Chan LS 2002 Incontinentia pigmenti: a review and update on the molecular basis of pathophysiology.
J. Am. Acad. Dermatol. 47: 169-187.
-
Berlit P, Stueper B, Fink I, Rebmann V, Hoyer P, Kreuzfelder E, Grosse-Wilde H 2005 Behcet's disease is associated with increased concentrations of antibodies against phosphatidylserine and ribosomal phosphoproteins.
Vasa 34: 176-180.
-
Bernal NP, Stehr W, Coyle R, Erwin CR, Warner BW 2006 Epidermal growth factor receptor signaling regulates Bax and Bcl-w expression and apoptotic responses during intestinal adaptation in mice.
Gastroenterology 130: 412-423.
*
-
Berndt U, Philipsen L, Bartsch S, Wiedenmann B, Baumgart DC, Hammerle M, Sturm A 2008 Systematic high-content proteomic analysis reveals substantial immunologic changes in colorectal cancer.
Cancer Res. 68: 880-888.
*
-
Bernstein CN, Leslie WD 2003 The pathophysiology of bone disease in gastrointestinal disease.
Eur. J. Gastroenterol. Hepatol. 15: 857-864.
-
Bernstein H, Holubec H, Bernstein C, Ignatenko N, Gerner E, Dvorak K, Besselsen D, Ramsey L, Dall'Agnol M, Blohm-Mangone KA, Padilla-Torres J, Cui H, Garewal H, Payne CM 2006 Unique dietary-related mouse model of colitis.
Inflamm. Bowel Dis. 12: 278-293.
*
-
Bernstein H, Payne CM, Kunke K, Crowley-Weber CL, Waltmire CN, Dvorakova K, Holubec H, Bernstein C, Vaillancourt RR, Raynes DA, Guerriero V, Garewal H 2004 A proteomic study of resistance to deoxycholate-induced apoptosis.
Carcinogenesis 25: 681-692.
*
-
Bernt C, Vennegeerts T, Beuers U, Rust C 2006 The human transcription factor AP-1 is a mediator of bile acid-induced liver cell apoptosis.
Biochem. Biophys. Res. Commun. 340: 800-806.
*
-
Bernuau D, Feldmann G, Degott C, Gisselbrecht C 1981 Ultrastructural lesions of bile ducts in primary biliary cirrhosis. A comparison with the lesions observed in graft versus host disease.
Hum. Pathol. 12: 782-793.
-
Berquin IM, Min Y, Wu R, Wu J, Perry D, Cline JM, Thomas MJ, Thornburg T, Kulik G, Smith A, Edwards IJ, D'Agostino R, Zhang H, Wu H, Kang JX, Chen YQ 2007 Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids.
J. Clin. Invest. 117: 1866-1875.
*
-
Bertin J, Nir WJ, Fischer CM, Tayber OV, Errada PR, Grant JR, Keilty JJ, Gosselin ML, Robison KE, Wong GH, Glucksmann MA, DiStefano PS 1999 Human CARD4 protein is a novel CED-4/Apaf-1 cell death family member that activates NF-kappaB.
J. Biol. Chem. 274: 12955-12958.
*
-
Bertolami MC 2005 Mechanisms of hepatotoxicity.
Arq. Bras. Cardiol. 85 Suppl. 4: 25-27.
-
Bertolino P, Schrage A, Bowen DG, Klugewitz K, Ghani S, Eulenburg K, Holz L, Hogg N, McCaughan GW, Hamann A 2005 Early intrahepatic antigen-specific retention of naive CD8(+) T cells is predominantly ICAM-1/LFA-1 dependent in mice.
Hepatology 42: 1063-1071.
*
-
Beuers U 2006 Mechanisms of action of ursodeoxycholic acid for treatment of primary sclerosing cholangitis.
Falk Workshop "Primary Sclerosing Cholangitis: Complications and Consequences", Moscow (Russia), June 11, 2006, p. 12. *
-
Beuers U 2006 Drug insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis.
Nat. Clin. Pract. Gastroenterol. Hepatol. 3: 318-328.
*
-
Beuers U 2003 Mechanisms of action of ursodeoxycholic acid in cholestasis.
Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 49-50. October 15-16. *
-
Beutler B 2001 Autoimmunity and apoptosis: the Crohn's connection.
Immunity 15: 5-14.
*
-
Beutler B, Bazzoni F 1998 TNF, apoptosis and autoimmunity: a common thread?
Blood Cells Mol. Dis. 24: 216-230.
*
-
Bezerra JA 2006 The next challenge in pediatric cholestasis: deciphering the pathogenesis of biliary atresia.
J. Pediatr. Gastroenterol. Nutr. 43: S23-S29.
*
-
Bharhani MS, Borojevic R, Basak S, Ho E, Zhou P, Croitoru K 2006 IL-10 protects mouse intestinal epithelial cells from Fas-induced apoptosis via modulating Fas expression and altering caspase-8 and FLIP expression.
Am. J. Physiol. Gastrointest. Liver Physiol. 291: G820-829.
*
-
Bharti AC, Takada Y, Shishodia S, Aggarwal BB 2004 Evidence that receptor activator of nuclear factor (NF)-kappaB ligand can suppress cell proliferation and induce apoptosis through activation of a NF-kappaB-independent and TRAF6-dependent mechanism.
J. Biol. Chem. 279: 6065-6076.
*
-
Bhat PV, Manolescu DC 2008 Role of vitamin A in determining nephron mass and possible relationship to hypertension.
J. Nutr. 138: 1407-1410.
*
-
Bhathal PS, Gall JA 1985 Deletion of hyperplastic biliary epithelial cells by apoptosis following removal of the proliferative stimulus.
Liver 5: 311-325.
-
Bhattacharjee RN, Park KS, Kumagai Y, Okada K, Yamamoto M, Uematsu S, Matsui K, Kumar H, Kawai T, Iida T, Honda T, Takeuchi O, Akira S 2006 VP1686, a Vibrio type III secretion protein, induces Toll-like receptor independent apoptosis in macrophage through NF-kappa B inhibition.
J. Biol. Chem. 281: 36897-36904.
*
-
Bhojani MS, Hamstra DA, Chang DC, Coppola JM, Khan AP, Reddy GR, Ross BD, Rehemtulla A 2006 Imaging of proteolytic activity using a conditional cell surface receptor.
Mol. Imaging 5: 129-137.
-
Bhutani M, Pathak AK, Nair AS, Kunnumakkara AB, Guha S, Sethi G, Aggarwal BB 2007 Capsaicin is a novel blocker of constitutive and interleukin-6-inducible STAT3 activation.
Clin. Cancer Res. 13: 3024-3032.
*
-
Bianchi G, Montecucco F, Bertolotto M, Dallegri F, Ottonello L 2007 Immune complexes induce monocyte survival through defined intracellular pathways.
Ann. N. Y. Acad. Sci. 1095: 209-219.
-
Bianchi ME, Manfredi AA 2007 High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity.
Immunol. Rev. 220: 35-46.
*
-
Bianchi R, Giambanco I, Donato R 2008 S100B/RAGE-dependent activation of microglia via NF-kappaB and AP-1 Co-regulation of COX-2 expression by S100B, IL-1beta and TNF-alpha.
Neurobiol. Aging Jul 1 [Epub ahead of print].
-
Bianchi SM, Prince LR, McPhillips K, Allen L, Marriott HM, Taylor GW, Hellewell PG, Sabroe I, Dockrell DH, Henson PW, Whyte MK 2008 Impairment of apoptotic cell engulfment by pyocyanin, a toxic metabolite of Pseudomonas aeruginosa.
Am. J. Respir. Crit. Care Med. 177: 35-43.
*
-
Biancone L, Palmieri G, Lombardi A, Vavassori P, Monteleone I, Del Vecchio Blanco G, Colantoni A, Spagnoli L, Tonelli F, Pallone F 2002 Cytoskeletal proteins and resident flora.
Dig. Liver Dis. 34 Suppl. 2: S34-S36.
-
Bickston SJ, Comerford LW, Cominelli F 2003 Future therapies for inflammatory bowel disease.
Curr. Gastroenterol. Rep. 5: 518-523.
-
Bihl F, Emmenegger U, Reichen J, Neftel KA, Zimmermann A, Cerny A 2006 Macrophage activating syndrome is associated with lobular hepatitis and severe bile duct injury with cholestasis.
J. Hepatol. 44: 1208-1212.
*
-
Bijl M, Kallenberg CG 2006 Ultraviolet light and cutaneous lupus.
Lupus 15: 724-727.
-
Bilezikci B, Demirhan B, Kocbiyik A, Arat Z, Haberal M 2008 Relevant histopathologic findings that distinguish acute cellular rejection from cholangitis in hepatic allograft biopsy specimens.
Transplant. Proc. 40: 248-250.
*
-
Billiet L, Furman C, Larigauderie G, Copin C, Page S, Fruchart JC, Brand K, Rouis M 2008 Enhanced VDUP-1 gene expression by PPARgamma agonist induces apoptosis in human macrophage.
J. Cell. Physiol. 214: 183-191.
*
-
Bilodeau M, Tousignant J, Ethier C, Rocheleau B, Raymond VA, Lapointe R 2004 Anti-apoptotic effect of insulin on normal hepatocytes in vitro and in vivo.
Apoptosis 9: 609-617.
-
Biondo PD, Brindley DN, Sawyer MB, Field CJ 2008 The potential for treatment with dietary long-chain polyunsaturated n-3 fatty acids during chemotherapy.
J. Nutr. Biochem. Jul 3 [Epub ahead of print].
*
-
Bishop GA 2004 The multifaceted roles of TRAFs in the regulation of B-cell function.
Nat. Rev. Immunol. 4: 775-786.
-
Bishop-Bailey D, Walsh DT, Warner TD 2004 Expression and activation of the farnesoid X receptor in the vasculature.
Proc. Natl. Acad. Sci. U.S.A. 101: 3668-3673.
*
-
Bisht S, Feldmann G, Soni S, Ravi R, Karikar C, Maitra A, Maitra A 2007 Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy.
J. Nanobiotechnology 5: 3.
*
-
Bissonnette RP, Brunner T, Lazarchik SB, Yoo NJ, Boehm MF, Green DR, Heyman RA 1995 9-cis Retinoic acid inhibition of activation-induced apoptosis is mediated via regulation of Fas ligand and requires retinoic acid receptor and retinoid X receptor activation.
Mol. Cell. Biol. 15: 5576-5585.
*
-
Bjornsson E, Chapman RW 2003 Sclerosing cholangitis.
Curr. Opin. Gastroenterol. 19: 270-275.
-
Black D, Bird MA, Samson CM, Lyman S, Lange PA, Schrum LW, Qian T, Lemasters JJ, Brenner DA, Rippe RA, Behrns KE 2004 Primary cirrhotic hepatocytes resist TGFbeta-induced apoptosis through a ROS-dependent mechanism.
J. Hepatol. 40: 942-951.
*
-
Blackburn SD, Shin H, Freeman GJ, Wherry EJ 2008 Selective expansion of a subset of exhausted CD8 T cells by alphaPD-L1 blockade.
Proc. Natl. Acad. Sci. U.S.A. Sep 22 [Epub ahead of print].
*
-
Blackwell NM, Sembi P, Newson JS, Lawrence T, Gilroy DW, Kabouridis PS 2004 Reduced infiltration and increased apoptosis of leukocytes at sites of inflammation by systemic administration of a membrane-permeable IkappaBalpha repressor.
Arthritis Rheum. 50: 2675-2684.
*
-
Blake DJ, Wetzel SA, Pfau JC 2008 Autoantibodies from mice exposed to Libby amphibole asbestos bind SSA/Ro52-enriched apoptotic blebs of murine macrophages.
Toxicology 246: 172-179.
*
-
Blandino-Rosano M, Perez-Arana G, Mellado-Gil J, Segundo C, Aguilar-Diosdado M 2008 Anti-proliferative effect of pro-inflammatory cytokines in cultured beta cells is associated with Erk1/2 pathway inhibition: protective role of GLP-1.
J. Mol. Endocrinol. 41: 35-44.
*
-
Blankenberg FG 2008 In vivo detection of apoptosis.
J. Nucl. Med. 49 Suppl. 2: 81S-95S.
-
Blatt NB, Boitano AE, Lyssiotis CA, Opipari AW Jr, Glick GD 2008 Bz-423 superoxide signals apoptosis via selective activation of JNK, Bak, and Bax.
Free Radic. Biol. Med. Aug 3 [Epub ahead of print].
-
Blazovics A, Hagymasi K, Pronai L 2004 Cytokines, prostaglandins, nutritive and non-nuitritive factors in inflammatory bowel diseases.
Orv. Hetil. 145: 2523-2529.
-
Blenman KR, Bahjat FR, Moldawer LL, Morel L 2004 Aberrant signaling in the TNFalpha/TNF receptor 1 pathway of the NZM2410 lupus-prone mouse.
Clin. Immunol. 110: 124-133.
*
-
Blomhoff HK 2004 Vitamin A regulates proliferation and apoptosis of human T- and B-cells.
Biochem. Soc. Trans. 32: 982-984.
*
-
Blossom SJ, Pumford NR, Gilbert KM 2004 Activation and attenuation of apoptosis of CD4(+) T cells following in vivo exposure to two common environmental toxicants, trichloroacetaldehyde hydrate and trichloroacetic acid.
J. Autoimmun. 23: 211-220.
-
Bluestone JA 2007 A balanced attack.
The Scientist May, 2007 (http://www.the-scientist.com/2007/05/01/s32/1/ ).
-
Bluethner T, Niederhagen M, Caca K, Serr F, Witzigmann H, Moebius C, Mossner J, Wiedmann M 2007 Inhibition of histone deacetylase for the treatment of biliary tract cancer: a new effective pharmacological approach.
World J. Gastroenterol. 13: 4761-4770.
*
-
Blyth K, Vaillant F, Hanlon L, Mackay N, Bell M, Jenkins A, Neil JC, Cameron ER 2006 Runx2 and MYC collaborate in lymphoma development by suppressing apoptotic and growth arrest pathways in vivo.
Cancer Res. 66: 2195-2201.
*
-
Bobe P, Bonardelle D, Benihoud K, Opolon P, Chelbi-Alix MK 2006 Arsenic trioxide: a novel promising therapeutic agent for lymphoproliferative and autoimmune syndromes in MRL/lpr mice.
Blood 108: 3967-3975.
*
-
Boberg KM, Schrumpf E 2004 Diagnosis and treatment of cholangiocarcinoma.
Curr. Gastroenterol. Rep. 6: 52-59.
-
Bocca C, Bozzo F, Martinasso G, Canuto RA, Miglietta A 2008 Involvement of PPARalpha in the growth inhibitory effect of arachidonic acid on breast cancer cells.
Br. J. Nutr. 100: 739-750.
*
-
Bocher V, Chinetti G, Fruchart JC, Staels B 2002 Role of the peroxisome proliferator-activated receptors (PPARS) in the regulation of lipids and inflammation control.
J. Soc. Biol. 196: 47-52.
-
Bockelmann R, Horn T, Gollnick H, Bonnekoh B 2005 Interferon-gamma-dependent in vitro model for the putative keratin 17 autoimmune loop in psoriasis: exploration of pharmaco- and gene-therapeutic effects.
Skin Pharmacol. Physiol. 18: 42-54.
-
Boehm I 2006 Apoptosis in physiological and pathological skin: implications for therapy.
Curr. Mol. Med. 6: 375-394.
-
Bogos K, Renyi-Vamos F, Kovacs G, Tovari J, Dome B 2008 Role of retinoic receptors in lung carcinogenesis.
J. Exp. Clin. Cancer Res. 27: 18.
-
Bohm I 2006 The apoptosis marker enzyme poly-(ADP-ribose) polymerase (PARP) in systemic lupus erythematosus.
Z. Rheumatol. 65: 541-544.
-
Bohnhorst J, Rasmussen T, Moen SH, Flottum M, Knudsen L, Borset M, Espevik T, Sundan A 2006 Toll-like receptors mediate proliferation and survival of multiple myeloma cells.
Leukemia 20: 1138-1144.
-
Boirivant M, Marini M, Di Felice G, Pronio AM, Montesani C, Tersigni R, Strober W 1999 Lamina propria T cells in Crohn's disease and other gastrointestinal inflammation show defective CD2 pathway-induced apoptosis.
Gastroenterology 116: 557-565.
-
Boitier E, Gautier JC, Roberts R 2003 Advances in understanding the regulation of apoptosis and mitosis by peroxisome-proliferator activated receptors in pre-clinical models: relevance for human health and disease.
Comp. Hepatol. 2: 3.
*
-
Bolstad AI, Wargelius A, Nakken B, Haga HJ, Jonsson R 2000 Fas and Fas ligand gene polymorphisms in primary Sjogren's syndrome.
J. Rheumatol. 27: 2397-2405.
-
Bonora E 2007 Protection of pancreatic beta-cells: is it feasible?
Nutr. Metab. Cardiovasc. Dis. 18: 74-83.
-
Borchers AT, Naguwa SM, Keen CL, Gershwin ME 2003 Immunopathogenesis of Sjogren's syndrome.
Clin. Rev. Allergy Immunol. 25: 89-104.
-
Borgognone M, Perez LM, Basiglio CL, Ochoa JE, Roma MG 2005 Signaling modulation of bile salt-induced necrosis in isolated rat hepatocytes.
Toxicol. Sci. 83: 114-125.
*
-
Boris M, Kaiser C, Golblatt A, Elice MW, Edelson SM, Adams JB, Feinstein DL 2007 Effect of pioglitazone treatment on behavioral symptoms in autistic children.
J. Neuroinflammation 4: 3.
*
-
Borutinskaite VV, Navakauskiene R, Magnusson KE 2006 Retinoic acid and histone deacetylase inhibitor BML-210 inhibit proliferation of human cervical cancer HeLa cells.
Ann. N. Y. Acad. Sci. 1091: 346-355.
*
-
Bose M, Hao X, Ju J, Husain A, Park S, Lambert JD, Yang CS 2007 Inhibition of tumorigenesis in Apc(Min/+) mice by a combination of (-)-epigallocatechin-3-gallate and fish oil.
J. Agric. Food Chem. 55: 7695-7700.
*
-
Bosisio D, Vulcano M, Del Prete A, Sironi M, Salvi V, Salogni L, Riboldi E, Leoni F, Dinarello CA, Girolomoni G, Sozzani S 2008 Blocking TH17-polarizing cytokines by histone deacetylase inhibitors in vitro and in vivo.
J. Leukoc. Biol. Sep 9 [Epub ahead of print].
*
-
Bosque A, Aguil JI, Del Rey M, Paz-Artal E, Allende LM, Naval J, Anel A 2008 Cell cycle regulation by FasL and Apo2L/TRAIL in human T-cell blasts. Implications for autoimmune lymphoproliferative syndromes.
J. Leukoc. Biol. 84: 488-498.
*
-
Bossowski A, Czarnocka B, Bardadin K, Stasiak-Barmuta A, Urban M, Dadan J, Ratomski K, Bossowska A 2008 Identification of apoptotic proteins in thyroid gland from patients with Graves' disease and Hashimoto's thyroiditis.
Autoimmunity 41: 163-173.
-
Bossowski A, Czarnocka B, Bardadin K, Urban M, Niedziela M, Dadan J 2008 Expression of Bcl-2 family proteins in thyrocytes from young patients with immune and nonimmune thyroid diseases.
Horm. Res. 70: 155-164.
-
Bossowski A, Czarnocka B, Stasiak-Barmuta A, Bardadin K, Urban M, Dadan J 2007 Analysis of Fas, FasL and caspase-8 expression in thyroid gland in young patients with immune and non-immune thyroid diseases.
Endokrynol. Pol. 58: 303-313.
-
Botchkarev VA 2003 Neurotrophins and their role in pathogenesis of alopecia areata.
J. Investig. Dermatol. Symp. Proc. 8: 195-198.
*
-
Botchkarev VA, Yaar M, Peters EM, Raychaudhuri SP, Botchkareva NV, Marconi A, Raychaudhuri SK, Paus R, Pincelli C 2006 Neurotrophins in skin biology and pathology.
J. Invest. Dermatol. 126: 1719-1727.
*
-
Bouchier-Hayes L, Conroy H, Egan H, Adrain C, Creagh EM, MacFarlane M, Martin SJ 2001 CARDINAL, a novel caspase recruitment domain protein, is an inhibitor of multiple NF-kappa B activation pathways.
J. Biol. Chem. 276: 44069-44077.
*
-
Bouchier-Hayes L, Martin SJ 2002 CARD games in apoptosis and immunity.
EMBO Rep. 3: 616-621.
*
-
Bouchier-Hayes L, Martin SJ 2004 CARDINAL roles in apoptosis and NFkappaB activation.
Vitam. Horm. 67: 133-147.
-
Bourne T, Fossati G, Nesbitt A 2008 A PEGylated Fab' fragment against tumor necrosis factor for the treatment of Crohn disease: exploring a new mechanism of action.
BioDrugs 22: 331-337.
-
Bowen JM, Stringer AM, Gibson RJ, Yeoh AS, Hannam S, Keefe DM 2007 VSL#3 probiotic treatment reduces chemotherapy-induced diarrhea and weight loss.
Cancer Biol. Ther. 6: 1449-1454.
-
Bowolaksono A, Nishimura R, Hojo T, Sakumoto R, Acosta TJ, Okuda K 2008 Anti-apoptotic roles of prostaglandin E2 and F2alpha in bovine luteal steroidogenic cells.
Biol. Reprod. 79: 310-317.
*
-
Brachemi S, Mambole A, Fakhouri F, Mouthon L, Guillevin L, Lesavre P, Halbwachs-Mecarelli L 2007 Increased membrane expression of proteinase 3 during neutrophil adhesion in the presence of anti-proteinase 3 antibodies.
J. Am. Soc. Nephrol. 18: 2330-2339.
-
Brand S, Beigel F, Olszak T, Zitzmann K, Eichhorst ST, Otte JM, Diepolder H, Marquardt A, Jagla W, Popp A, Leclair S, Herrmann K, Seiderer J, Ochsenkuhn T, Goke B, Auernhammer CJ, Dambacher J 2006 IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration.
Am. J. Physiol. Gastrointest. Liver Physiol. 290: G827-G838.
*
-
Brand S, Olszak T, Beigel F, Diebold J, Otte JM, Eichhorst ST, Goke B, Dambacher J 2006 Cell differentiation dependent expressed CCR6 mediates ERK-1/2, SAPK/JNK, and Akt signaling resulting in proliferation and migration of colorectal cancer cells.
J. Cell. Biochem. 97: 709-723.
*
-
Brandlein S, Pohle T, Vollmers C, Wozniak E, Ruoff N, Muller-Hermelink HK, Vollmers HP 2004 CFR-1 receptor as target for tumor-specific apoptosis induced by the natural human monoclonal antibody PAM-1.
Oncol. Rep. 11: 777-784.
-
Brandt S, Heller H, Schuster KD, Grote J 2004 Tamoxifen induces suppression of cell viability and apoptosis in the human hepatoblastoma cell line HepG2 via down-regulation of telomerase activity.
Liver Int. 24: 46-54.
*
-
Brechot C 2004 Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms.
Gastroenterology 127 (5 Suppl. 2): S56-S61.
*
-
Bregenholt S, Brimnes J, Nissen MH, Claesson MH 1999 In vitro activated CD4+ T cells from interferon-gamma (IFN-gamma)-deficient mice induce intestinal inflammation in immunodeficient hosts.
Clin. Exp. Immunol. 118: 228-234.
*
-
Briganti S, Picardo M 2003 Antioxidant activity, lipid peroxidation and skin diseases. What's new.
J. Eur. Acad. Dermatol. Venereol. 17: 663-669.
*
-
Brockhausen I 2006 The role of galactosyltransferases in cell surface functions and in the immune system.
Drug News Perspect. 19: 401-409.
-
Brooling JT, Campbell JS, Mitchell C, Yeoh GC, Fausto N 2005 Differential regulation of rodent hepatocyte and oval cell proliferation by interferon gamma.
Hepatology 41: 906-915.
*
-
Brown JM, Schwanke CM, Pershouse MA, Pfau JC, Holian A 2005 Effects of rottlerin on silica-exacerbated systemic autoimmune disease in New Zealand mixed mice.
Am. J. Physiol. Lung Cell. Mol. Physiol. 289: L990-L998.
*
-
Brown KD, Claudio E, Siebenlist U 2008 The roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis.
Arthritis Res. Ther. 10: 212.
-
Brown L, Ongusaha PP, Kim HG, Nuti S, Mandinova A, Lee JW, Khosravi-Far R, Aaronson SA, Lee SW 2007 CDIP, a novel pro-apoptotic gene, regulates TNFalpha-mediated apoptosis in a p53-dependent manner.
EMBO J. 26: 3410-3422.
*
-
Brown WA, Farmer KC, Skinner SA, Malcontenti-Wilson C, Misajon A, O'Brien PE 2000 5-Aminosalicyclic acid and olsalazine inhibit tumor growth in a rodent model of colorectal cancer.
Dig. Dis. Sci. 45: 1578-1584.
*
-
Brtko J 2007 Retinoids, rexinoids and their cognate nuclear receptors: character and their role in chemoprevention of selected malignant diseases.
Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 151: 187-194.
*
-
Brtko J 2007 Role of retinoids and their cognate nuclear receptors in breast cancer chemoprevention.
Cent. Eur. J. Public Health 15: 3-6.
-
Bruewer M, Luegering A, Kucharzik T, Parkos CA, Madara JL, Hopkins AM, Nusrat A 2003 Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms.
J. Immunol. 171: 6164-6172.
*
-
Brun T, Gauthier BR 2008 A focus on the role of Pax4 in mature pancreatic islet beta-cell expansion and survival in health and disease.
J. Mol. Endocrinol. 40: 37-45.
*
-
Brunn A, Utermohlen O, Carstov M, Sanchez Ruiz M, Miletic H, Schluter D, Deckert M 2008 CD4 T cells mediate axonal damage and spinal cord motor neuron apoptosis in murine P0106-125-induced experimental autoimmune neuritis.
Am. J. Pathol. 173: 93-105.
*
-
Brunner T, Arnold D, Wasem C, Laissue JA, Mueller C 1999 Death receptor-mediated suicide: a novel target of autoimmune disease treatment.
Expert Opin. Investig. Drugs 8: 1359-1372.
-
Brzoska T, Luger TA, Maaser C, Abels C, Bohm M 2008 alpha-Melanocyte-stimulating hormone and related tripeptides: biochemistry, anti-inflammatory and protective effects in vitro and in vivo and future perspectives for the treatment of immune-mediated inflammatory diseases.
Endocr. Rev. 29: 581-602.
*
-
Bu D, Tomlinson G, Lewis CM, Zhang C, Kildebeck E, Euhus DM 2006 An intronic polymorphism associated with increased XRCC1 expression, reduced apoptosis and familial breast cancer.
Breast Cancer Res. Treat. 99: 257-265.
*
-
Bu P, Wan YJ 2007 Fenretinide-induced apoptosis of Huh-7 hepatocellular carcinoma is retinoic acid receptor beta dependent.
BMC Cancer 7: 236.
*
-
Bubici C, Papa S, Pham CG, Zazzeroni F, Franzoso G 2004 NF-kappaB and JNK: an intricate affair.
Cell Cycle 3: 1524-1529.
*
-
Buchsbaum DJ, Forero-Torres A, Lobuglio AF 2007 TRAIL-receptor antibodies as a potential cancer treatment.
Future Oncol. 3: 405-409.
-
Buck J, Myc A, Garbe A, Cathomas G 1991 Differences in the action and metabolism between retinol and retinoic acid in B lymphocytes.
J. Cell Biol. 115: 851-859.
*
-
Buck M, Chojkier M 2007 C/EBPbeta associates with caspase 8 complex proteins and modulates apoptosis in hepatic stellate cells.
J. Clin. Gastroenterol. 41: S295-S299.
-
Buck M, Chojkier M 2007 A ribosomal S-6 kinase-mediated signal to C/EBP-beta is critical for the development of liver fibrosis.
PLoS ONE 2: e1372.
*
-
Buckley NE 2008 The peripheral cannabinoid receptor knockout mice: an update.
Br. J. Pharmacol. 153: 309-318.
*
-
Buckley RH 2004 Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution.
Annu. Rev. Immunol. 22: 625-655.
*
-
Buendia MA 2006 Liver cancer.
Falk Symposium 156. XIII Falk Liver Week (Part II). GENETICS IN LIVER DISEASES, Freiburg (Germany), October 8-9, 2006, p. 20-21. *
-
Bulwin GC, Walter S, Schlawinsky M, Heinemann T, Schulze A, Hohne W, Krause G, Kalka-Moll W, Fraser P, Volk HD, Lohler J, Milford EL, Utku N 2008 HLA-DR alpha 2 mediates negative signalling via binding to Tirc7 leading to anti-inflammatory and apoptotic effects in lymphocytes in vitro and in vivo.
PLoS ONE 3: e1576.
*
-
Bunger M, van den Bosch HM, van der Meijde J, Kersten S, Hooiveld GJ, Muller M 2007 Genome-wide analysis of PPARalpha activation in murine small intestine.
Physiol. Genomics 30: 192-204.
*
-
Burgermeister E, Chuderland D, Hanoch T, Meyer M, Liscovitch M, Seger R 2007 Interaction with MEK causes nuclear export and downregulation of PPARgamma.
Mol. Cell. Biol. 27: 803-817.
*
-
Burkly LC, Michaelson JS, Hahm K, Jakubowski A, Zheng TS 2007 TWEAKing tissue remodeling by a multifunctional cytokine: role of TWEAK/Fn14 pathway in health and disease.
Cytokine 40: 1-16.
-
Burstein E, Ganesh L, Dick RD, Van De Sluis B, Wilkinson JC, Klomp LW, Wijmenga C, Brewer GJ, Nabel GJ, Duckett CS 2004 A novel role for XIAP in copper homeostasis through regulation of MURR1.
EMBO J. 23: 244-254.
*
-
Burt AD 2002 Primary biliary cirrhosis and other ductopenic diseases.
Clin. Liver Dis. 6: 363-380.
-
Burt AD 2004 Spectrum of liver pathology in immune mediated liver diseases.
J. Gastroenterol. Hepatol. 19: S353-S355. *
-
Burton JD, Castillo ME, Goldenberg DM, Blumenthal RD 2007 Peroxisome proliferator-activated receptor-gamma antagonists exhibit potent antiproliferative effects versus many hematopoietic and epithelial cancer cell lines.
Anticancer Drugs 18: 525-534.
-
Bus PJ, Nagtegaal ID, Verspaget HW, Lamers CB, Geldof H, Van Krieken JH, Griffioen G 1999 Mesalazine-induced apoptosis of colorectal cancer: on the verge of a new chemopreventive era?
Aliment. Pharmacol. Ther. 13: 1397-1402.
*
-
Busteed S, Bennett MW, Molloy C, Houston A, Stone MA, Shanahan F, Molloy MG, O'Connell J 2006 Bcl-x(L) expression in vivo in rheumatoid synovium.
Clin. Rheumatol. 25: 789-793.
*
-
Butt C, Peddle L, Greenwood C, Hamilton S, Gladman D, Rahman P 2006 Association of functional variants of PTPN22 and tp53 in psoriatic arthritis: a case-control study.
Arth. Res. Ther. 8: R27-R30.
*
-
Byrne B, Welsh J 2007 Identification of novel mediators of vitamin D signaling and 1,25(OH)(2)D(3) resistance in mammary cells.
J. Steroid Biochem. Mol. Biol. 103: 703-707.
-
Cabot MC, Giuliano AE, Han TY, Liu YY 1999 SDZ PSC 833, the cyclosporine A analogue and multidrug resistance modulator, activates ceramide synthesis and increases vinblastine sensitivity in drug-sensitive and drug-resistant cancer cells.
Cancer Res. 59: 880-885.
*
-
Cai W, Wu J, Hong L, Xu Y, Tang Q, Shi C 2006 Oxidative injury and hepatocyte apoptosis in total parenteral nutrition-associated liver dysfunction.
J. Pediatr. Surg. 41: 1663-1668.
-
Cales P 1998 Apoptosis and liver fibrosis: antifibrotic strategies.
Biomed. Pharmacother. 52: 259-263.
-
Cals-Grierson MM, Ormerod AD 2004 Nitric oxide function in the skin.
Nitric Oxide 10: 179-193.
*
-
Calviello G, Resci F, Serini S, Piccioni E, Toesca A, Boninsegna A, Monego G, Ranelletti FO, Palozza P 2007 Docosahexaenoic acid induces proteasome-dependent degradation of beta-catenin, down-regulation of survivin and apoptosis in human colorectal cancer cells not expressing COX-2.
Carcinogenesis 28: 1202-1209.
*
-
Calvisi DF, Ladu S, Gorden A, Farina M, Conner EA, Lee JS, Factor VM, Thorgeirsson SS 2006 Ubiquitous activation of Ras and Jak/Stat pathways in human HCC.
Gastroenterology 130: 1117-1128.
*
-
Campbell S, Burkly LC, Gao HX, Berman JW, Su L, Browning B, Zheng T, Schiffer L, Michaelson JS, Putterman C 2006 Proinflammatory effects of TWEAK/Fn14 interactions in glomerular mesangial cells.
J. Immunol. 176: 1889-1898.
*
-
Campbell S, Michaelson J, Burkly L, Putterman C 2004 The role of TWEAK/Fn14 IN the pathogenesis of inflammation and systemic autoimmunity.
Front. Biosci. 9: 2273-2284.
-
Camplejohn RS, Hodgson S, Carter N, Kato BS, Spector TD 2006 Heritability of DNA-damage-induced apoptosis and its relationship with age in lymphocytes from female twins.
Br. J. Cancer 95: 520-524.
*
-
Canale-Zambrano JC, Poffenberger MC, Cory SM, Humes DG, Haston CK 2007 Intestinal phenotype of variable-weight cystic fibrosis knockout mice.
Am. J. Physiol. Gastrointest. Liver Physiol. 293: G222-G229.
*
-
Canbay A, Feldstein A, Baskin-Bey E, Bronk SF, Gores GJ 2004 The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse.
J. Pharmacol. Exp. Ther. 308: 1191-1196.
*
-
Canbay A, Guicciardi ME, Higuchi H, Feldstein A, Bronk SF, Rydzewski R, Taniai M, Gores GJ 2003 Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis.
J. Clin. Invest. 112: 152-159.
*
-
Cannon CL, Kowalski MP, Stopak KS, Pier GB 2003 Pseudomonas aeruginosa-induced apoptosis is defective in respiratory epithelial cells expressing mutant cystic fibrosis transmembrane conductance regulator.
Am. J. Respir. Cell. Mol. Biol. 29: 188-197.
*
-
Cantaert T, De Rijcke L, Mavragani CP, Wijbrandts CA, Niewold TB, Niers T, Vandooren B, Veys EM, Richel D, Tak PP, Crow MK, Baeten D 2008 Exposure to nuclear antigens contributes to the induction of humoral autoimmunity during TNF alpha blockade.
Ann. Rheum. Dis. Jul 14 [Epub ahead of print].
-
Cao L, Du P, Jiang SH, Jin GH, Huang QL, Hua ZC 2008 Enhancement of antitumor properties of TRAIL by targeted delivery to the tumor neovasculature.
Mol. Cancer Ther. 7: 851-861.
-
Cao LQ, Chen XL, Wang Q, Huang XH, Zhen MC, Zhang LJ, Li W, Bi J 2007 Upregulation of PTEN involved in rosiglitazone-induced apoptosis in human hepatocellular carcinoma cells.
Acta Pharmacol. Sin. 28: 879-887.
-
Cao X, Liu W, Lin F, Li H, Kolluri SK, Lin B, Han YH, Dawson MI, Zhang XK 2004 Retinoid X receptor regulates Nur77/TR3-dependent apoptosis by modulating its nuclear export and mitochondrial targeting.
Mol. Cell. Biol. 24: 9705-9725.
*
-
Caparbo VF, Prada F, Silva CA, Regio PL, Pereira RM 2008 Serum from children with polyarticular juvenile idiopathic arthritis (pJIA) inhibits differentiation, mineralization and may increase apoptosis of human osteoblasts "in vitro".
Clin. Rheumatol. Aug 7 [Epub ahead of print].
-
Capocasale RJ, Makropoulos DA, Achuthanandam R, Stowell N, Quinn J, Rafferty PA, O'Brien J, Emmell E, Bugelski PJ 2008 Myelodysplasia and anemia of chronic disease in human tumor necrosis factor-alpha transgenic mice.
Cytometry A. 73: 148-159.
-
Caprioli F, Stolfi C, Caruso R, Fina D, Sica G, Biancone L, Pallone F, Monteleone G 2008 Transcriptional and post-translational regulation of Flip, an inhibitor of Fas-mediated apoptosis, in human gut inflammation.
Gut Jul 14 [Epub ahead of print].
-
Cario EL, Gerken GU, Podolsky DA 2007 Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function.
Gastroenterology 132: 1359-1374.
*
-
Carnahan J, Stein R, Qu Z, Hess K, Cesano A, Hansen HJ, Goldenberg DM 2007 Epratuzumab, a CD22-targeting recombinant humanized antibody with a different mode of action from rituximab.
Mol. Immunol. 44: 1331-1341.
*
-
Carneiro-Sampaio M, Liphaus BL, Jesus AA, Silva CA, Oliveira JB, Kiss MH 2008 Understanding systemic lupus erythematosus physiopathology in the light of primary immunodeficiencies.
J. Clin. Immunol. 28 Suppl. 1: S34-S41.
*
-
Carol M, Borruel N, Antolin M, Llopis M, Casellas F, Guarner F, Malagelada JR 2006 Modulation of apoptosis in intestinal lymphocytes by a probiotic bacteria in Crohn's disease.
J. Leukoc. Biol. 79: 917-922.
*
-
Carter CJ 2008 Interactions between the products of the Herpes simplex genome and Alzheimer's disease susceptibility genes: relevance to pathological-signalling cascades.
Neurochem. Int. 52: 920-934.
-
Cassan C, Piaggio E, Zappulla JP, Mars LT, Couturier N, Bucciarelli F, Desbois S, Bauer J, Gonzalez-Dunia D, Liblau RS 2006 Pertussis toxin reduces the number of splenic Foxp3+ regulatory T cells.
J. Immunol. 177: 1552-1560.
*
-
Cassatella MA 2006 On the production of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2L) by human neutrophils.
J. Leukoc. Biol. 79: 1140-1149.
*
-
Cassatella MA, da Silva GP, Tinazzi I, Facchetti F, Scapini P, Calzetti F, Tamassia N, Wei P, Nardelli B, Roschke V, Vecchi A, Mantovani A, Bambara LM, Edwards SW, Carletto A 2007 Soluble TNF-like cytokine (TL1A) production by immune complexes stimulated monocytes in rheumatoid arthritis.
J. Immunol. 178: 7325-7333.
*
-
Castellino G, Corallini F, Trotta F, Secchiero P 2007 Elevated levels of TRAIL in systemic lupus erythematosus are associated to the presence of anti-SSA/SSB antibodies.
Lupus 16: 479-482.
-
Castera L, Hatzfeld-Charbonnier AS, Ballot C, Charbonnel F, Dhuiege E, Velu T, Formstecher P, Mortier L, Marchetti P 2008 Apoptosis-related mitochondrial dysfunction defines human monocyte-derived dendritic cells with impaired immuno-stimulatory capacities.
J. Cell. Mol. Med. May 2 [Epub ahead of print].
*
-
Castro RE, Sola S, Ma X, Ramalho RM, Kren BT, Steer CJ, Rodrigues CM 2005 A distinct microarray gene expression profile in primary rat hepatocytes incubated with ursodeoxycholic acid.
J. Hepatol. 42: 897-906.
*
-
Castro RE, Sola S, Ramalho RM, Steer CJ, Rodrigues CM 2004 The bile acid tauroursodeoxycholic acid modulates phosphorylation and translocation of Bad via phosphatidylinositol 3-kinase in glutamate-induced apoptosis of rat cortical neurons.
J. Pharmacol. Exp. Ther. 311: 845-852.
*
-
Cataldegirmen G, Zeng S, Feirt N, Ippagunta N, Dun H, Qu W, Lu Y, Rong LL, Hofmann MA, Kislinger T, Pachydaki SI, Jenkins DG, Weinberg A, Lefkowitch J, Rogiers X, Yan SF, Schmidt AM, Emond JC 2005 RAGE limits regeneration after massive liver injury by coordinated suppression of TNF-alpha and NF-kappaB.
J. Exp. Med. 201: 473-484.
*
-
Catarzi S, Marcucci T, Papucci L, Favilli F, Donnini M, Tonelli F, Vincenzini MT, Iantomasi T 2008 Apoptosis and Bax, Bcl-2, Mcl-1 expression in neutrophils of Crohn's disease patients.
Inflamm. Bowel Dis. 14: 819-825.
-
Cauwe B, Martens E, Van den Steen PE, Proost P, Van Aelst I, Blockmans D, Opdenakker G 2008 Adenylyl cyclase-associated protein-1/CAP1 as a biological target substrate of gelatinase B/MMP-9.
Exp. Cell Res. 314: 2739-2749.
*
-
Cauwels A, Brouckaert P 2007 Survival of TNF toxicity: dependence on caspases and NO.
Arch. Biochem. Biophys. 462: 132-139.
*
-
Cawthorn WP, Heyd F, Hegyi K, Sethi JK 2007 Tumour necrosis factor-alpha inhibits adipogenesis via a beta-catenin/TCF4(TCF7L2)-dependent pathway.
Cell Death Differ. 14: 1361-1373.
-
Cazanave S, Vadrot N, Tinel M, Berson A, Lettéron P, Larosche I, Descatoire V, Feldmann G, Robin MA, Pessayre D 2008 Ibuprofen administration attenuates serum TNF-alpha levels, hepatic glutathione depletion, hepatic apoptosis and mouse mortality after Fas stimulation.
Toxicol. Appl. Pharmacol. 231: 336-343.
-
Cenedeze MA, Goncalves GM, Feitoza CQ, Wang PM, Damiao MJ, Bertocchi AP, Pacheco-Silva A, Camara NO 2007 The role of Toll-like receptor 4 in cisplatin-induced renal injury.
Transplant. Proc. 39: 409-411.
*
-
Cernaianu G, Brandmaier P, Scholz G, Ackermann OP, Alt R, Rothe K, Cross M, Witzigmann H, Tröbs RB 2008 All-trans retinoic acid arrests neuroblastoma cells in a dormant state. Subsequent nerve growth factor/brain-derived neurotrophic factor treatment adds modest benefit.
J. Pediatr. Surg. 43: 1284-1294.
-
Cervio E, Volta U, Verri M, Boschi F, Pastoris O, Granito A, Barbara G, Parisi C, Felicani C, Tonini M, De Giorgio R 2007 Sera of patients with celiac disease and neurologic disorders evoke a mitochondrial-dependent apoptosis in vitro.
Gastroenterology 133: 195-206.
*
-
Cha S, Brayer J, Gao J, Brown V, Killedar S, Yasunari U, Peck AB 2004 A dual role for interferon-gamma in the pathogenesis of Sjogren's syndrome-like autoimmune exocrinopathy in the nonobese diabetic mouse.
Scand. J. Immunol. 60: 552-565.
*
-
Chae BS, Shin TY 2007 Immunoregulatory abnormalities of T cells and hyperreactivity of B cells in the in vitro immune response in pristane-induced lupus mice.
Arch. Pharm. Res. 30: 191-198.
-
Chalaris A, Rabe B, Paliga K, Lange H, Laskay T, Fielding CA, Jones SA, Rose-John S, Scheller J 2007 Apoptosis is a natural stimulus of IL6R shedding and contributes to the pro-inflammatory trans-signaling function of neutrophils.
Blood 110: 1748-1755.
*
-
Chamaillard M, Girardin SE, Viala J, Philpott DJ 2003 Nods, Nalps and Naip: intracellular regulators of bacterial-induced inflammation.
Cell Microbiol. 5: 581-592.
*
-
Chambers KT, Weber SM, Corbett JA 2007 PGJ2 stimulated beta-cell apoptosis is associated with prolonged UPR activation.
Am. J. Physiol. Endocrinol. Metab. 292: E1052-E1061.
*
-
Chan TA 2002 Nonsteroidal anti-inflammatory drugs, apoptosis, and colon-cancer chemoprevention.
Lancet Oncol. 3: 166-174.
-
Chang L, Kamata H, Solinas G, Luo JL, Maeda S, Venuprasad K, Liu YC, Karin M 2006 The E3 ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP(L) turnover.
Cell 124: 601-613.
*
-
Chang X, Yamada R, Suzuki A, Kochi Y, Sawada T, Yamamoto K 2005 Citrullination of fibronectin in rheumatoid arthritis synovial tissue.
Rheumatology (Oxford) 44: 1374-1382.
*
-
Chang X, Yamada R, Suzuki A, Sawada T, Yoshino S, Tokuhiro S, Yamamoto K 2005 Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis.
Rheumatology (Oxford) 44: 40-50.
*
-
Chang YC, Chen TC, Lee CT, Yang CY, Wang HW, Wang CC, Hsieh SL 2008 Epigenetic control of MHC-II expression in tumor-associated macrophages by decoy receptor 3.
Blood 111: 5054-5063.
*
-
Chao C, Youssef J, Rezaiekhaleigh M, Birnbaum LS, Badr M 2002 Senescence-associated decline in hepatic peroxisomal enzyme activities corresponds with diminished levels of retinoid X receptor alpha, but not peroxisome proliferator-activated receptor alpha.
Mech. Ageing Dev. 123: 1469-1476.
-
Chapman KE, Coutinho A, Gray M, Gilmour JS, Savill JS, Seckl JR 2006 Local amplification of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1 and its role in the inflammatory response.
Ann. N. Y. Acad. Sci. 1088: 265-273.
*
-
Chapman RW 2003 The management of primary sclerosing cholangitis.
Curr. Gastroenterol. Rep. 5: 9-17.
-
Chapman RW 2004 High dose ursodeoxycholic acid in the treatment of primary sclerosing cholangitis.
Falk Symposium 141. XVIII International Bile Acid Meeting: Bile Acid Biology and its Therapeutic Implications. Stockholm (Sweden). p. 75. June 18-19. *
-
Chapoval SP, Al-Garawi A, Lora JM, Strickland I, Ma B, Lee PJ, Homer RJ, Ghosh S, Coyle AJ, Elias JA 2007 Inhibition of NF-kappaB activation reduces the tissue effects of transgenic IL-13.
J. Immunol. 179: 7030-7041.
-
Chatenoud L, Bluestone JA 2007 CD3-specific antibodies: a portal to the treatment of autoimmunity.
Nat. Rev. Immunol. 7: 622-632.
-
Chattopadhyay N 2006 Effects of calcium-sensing receptor on the secretion of parathyroid hormone-related peptide and its impact on humoral hypercalcemia of malignancy.
Am. J. Physiol. Endocrinol. Metab. 290: E761-E770.
*
-
Chaturvedi RK, Flint Beal M 2008 PPAR: a therapeutic target in Parkinson's disease.
J. Neurochem. 106: 506-518.
*
-
Chen A, Liu S, Park D, Kang Y, Zheng G 2007 Depleting intratumoral CD4+CD25+ regulatory T cells via FasL protein transfer enhances the therapeutic efficacy of adoptive T cell transfer.
Cancer Res. 67: 1291-1298.
*
-
Chen B, Zhang Y, Liu G, Guan GJ, Hou XH, Li XG, Liu JL 2008 Effects of valsartan, mycophenolate mofetil and their combined application on TRAIL and nuclear factor-kappaB expression in the kidneys of diabetic rats.
Zhonghua Yi Xue Za Zhi 88: 540-545.
-
Chen G, Goeddel DV 2002 TNF-R1 signaling: a beautiful pathway.
Science 296: 1634-1635.
*
-
Chen GG, Xu H, Lee JF, Subramaniam M, Leung KL, Wang SH, Chan UP, Spelsberg TC 2003 15-Hydroxy-eicosatetraenoic acid arrests growth of colorectal cancer cells via a peroxisome proliferator-activated receptor gamma-dependent pathway.
Int. J. Cancer 107: 837-843.
*
-
Chen JS, Mehta K 1999 Tissue transglutaminase: an enzyme with a split personality.
Int. J. Biochem. Cell. Biol. 31: 817-836.
*
-
Chen JY, Wang CM, Lu SC, Chou YH, Luo SF 2006 Association of apoptosis-related microsatellite polymorphisms on chromosome 1q in Taiwanese systemic lupus erythematosus patients.
Clin. Exp. Immunol. 143: 281-287.
*
-
Chen JY, Wang CM, Ma CC, Chow YH, Luo SF 2005 The -844C/T polymorphism in the Fas ligand promoter associates with Taiwanese SLE.
Genes Immun. 6: 123-128.
*
-
Chen K, Wei Y, Sharp GC, Braley-Mullen H 2007 Decreasing TNF-alpha results in less fibrosis and earlier resolution of granulomatous experimental autoimmune thyroiditis.
J. Leukoc. Biol. 81: 306-314.
*
-
Chen LW, Chang WJ, Chen PH, Liu WC, Hsu CM 2008 TLR ligand decreases mesenteric ischemia and reperfusion injury-induced gut damage through TNF-alpha signaling.
Shock Feb 28 [Epub ahead of print].
-
Chen M, Huang L, Shabier Z, Wang J 2007 Regulation of the lifespan in dendritic cell subsets.
Mol. Immunol. 44: 2558-2565.
*
-
Chen M, Huang L, Wang J 2007 Deficiency of Bim in dendritic cells contributes to over-activation of lymphocytes and autoimmunity.
Blood 109: 4360-4367.
*
-
Chen M, Wang YH, Wang Y, Huang L, Sandoval H, Liu YJ, Wang J 2006 Dendritic cell apoptosis in the maintenance of immune tolerance.
Science 311: 1160-1164.
*
-
Chen MC, Mudge CS, Klumpp D 2006 Urothelial lesion formation is mediated by TNFR1 during neurogenic cystitis.
Am. J. Physiol. Renal Physiol. 291: F741-F749.
*
-
Chen NJ, Chio II, Lin WJ, Duncan G, Chau H, Katz D, Huang HL, Pike KA, Hao Z, Su YW, Yamamoto K, de Pooter RF, Zuniga-Pflucker JC, Wakeham A, Yeh WC, Mak TW 2008 Beyond tumor necrosis factor receptor: TRADD signaling in Toll-like receptors.
Proc. Natl. Acad. Sci. U.S.A. 105: 12429-12434.
*
-
Chen RH, Chang CT, Wang TY, Huang WL, Tsai CH, Tsai FJ 2008 p53 codon 72 proline/arginine polymorphism and autoimmune thyroid diseases.
J. Clin. Lab. Anal. 22: 321-326.
-
Chen XM, LaRusso NF 2002 Cryptosporidiosis and the pathogenesis of AIDS-cholangiopathy.
Semin. Liver Dis. 22: 277-289.
-
Chen XM, Levine SA, Tietz P, Krueger E, McNiven MA, Jefferson DM, Mahle M, LaRusso NF 1998 Cryptosporidium parvum is cytopathic for cultured human biliary epithelia via an apoptotic mechanism.
Hepatology 28: 906-913.
*
-
Chen Y, Chong MM, Darwiche R, Thomas HE, Kay TW 2004 Severe pancreatitis with exocrine destruction and increased islet neogenesis in mice with suppressor of cytokine signaling-1 deficiency.
Am. J. Pathol. 165: 913-921.
*
-
Chen Y, Liu CP, Xu KF, Mao XD, Lu YB, Fang L, Yang JW, Liu C 2008 Effect of taurine-conjugated ursodeoxycholic acid on endoplasmic reticulum stress and apoptosis induced by advanced glycation end products in cultured mouse podocytes.
Am. J. Nephrol. 28: 1014-1022.
-
Chen YL, Yu CK, Lei HY 1999 Propionibacterium acnes induces acute TNFalpha-mediated apoptosis of hepatocytes followed by inflammatory T-cell-mediated granulomatous hepatitis in mice.
J. Biomed. Sci. 6: 349-356.
-
Chen ZY, Istfan NW 2000 Docosahexaenoic acid is a potent inducer of apoptosis in HT-29 colon cancer cells.
Prostaglandins Leukot. Essent. Fatty Acids 63: 301-308.
*
-
Cheng W, Cheng NS, Xiong XZ, Xia QJ, Chen OY, Yan NH, Jing J 2006 Expression of PPAR-gamma in human hilar bile duct carcinoma cell line QBC939 and the effects of PPAR-Y activated by its ligand on the growth of QBC939.
Sichuan Da Xue Xue Bao Yi Xue Ban 37: 745-749.
-
Cheng Y, Ohlsson L, Duan RD 2004 Psyllium and fat in diets differentially affect the activities and expressions of colonic sphingomyelinases and caspase in mice.
Br. J. Nutr. 91: 715-723.
*
-
Cheng Y, Tauschel HD, Nilsson A, Duan RD 1999 Ursodeoxycholic acid increases the activities of alkaline sphingomyelinase and caspase-3 in the rat colon.
Scand. J. Gastroenterol. 34: 915-920.
*
-
Cherkaoui-Malki M, Meyer K, Cao WQ, Latruffe N, Yeldandi AV, Rao MS, Bradfield CA, Reddy JK 2001 Identification of novel peroxisome proliferator-activated receptor alpha (PPARalpha) target genes in mouse liver using cDNA microarray analysis.
Gene Expr. 9: 291-304.
-
Chern CL, Huang RF, Chen YH, Cheng JT, Liu TZ 2001 Folate deficiency-induced oxidative stress and apoptosis are mediated via homocysteine-dependent overproduction of hydrogen peroxide and enhanced activation of NF-kappaB in human Hep G2 cells.
Biomed. Pharmacother. 55: 434-442.
-
Cheung KJ, Li G, Urban TA, Goldberg JB, Griffith A, Lu F, Burns JL 2007 Pilus-mediated epithelial cell death in response to infection with Burkholderia cenocepacia.
Microbes Infect. 9: 829-837.
*
-
Cheung RS, Brooling JT, Johnson MM, Riehle KJ, Campbell JS, Fausto N 2007 Interactions between MYC and transforming growth factor alpha alter the growth and tumorigenicity of liver progenitor cells.
Carcinogenesis 28: 2624-2631.
*
-
Chi CH, Liu IL, Lo WY, Liaw BS, Wang YS, Chi KH 2005 Hepatocyte growth factor gene therapy prevents radiation-induced liver damage.
World J. Gastroenterol. 11: 1496-1502.
*
-
Chia FL, Leong KP 2007 Severe cutaneous adverse reactions to drugs.
Curr. Opin. Allergy Clin. Immunol. 7: 304-309.
-
Chiang N, Schwab JM, Fredman G, Kasuga K, Gelman S, Serhan CN 2008 Anesthetics impact the resolution of inflammation.
PLoS ONE 3: e1879.
*
-
Chiang PC, Chien CL, Pan SL, Chen WP, Teng CM, Shen YC, Guh JH 2005 Induction of endoplasmic reticulum stress and apoptosis by a marine prostanoid in human hepatocellular carcinoma.
J. Hepatol. 43: 679-686.
*
-
Chida Y, Sudo N, Takaki A, Kubo C 2005 The hepatic sympathetic nerve plays a critical role in preventing Fas induced liver injury in mice.
Gut 54: 994-1002.
*
-
Chinetti G, Fruchart JC, Staels B 2001 Peroxisome proliferator-activated receptors (PPARs): nuclear receptors with functions in the vascular wall.
Z. Kardiol. 90 Suppl. 3: 125-132.
-
Chinetti G, Fruchart JC, Staels B 2000 Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation.
Inflamm. Res. 49: 497-505.
*
-
Chintharlapalli S, Papineni S, Safe S 2006 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit colon cancer cell and tumor growth through PPARgamma-dependent and PPARgamma-independent pathways.
Mol. Cancer Ther. 5: 1362-1370.
-
Chiou SK, Tanigawa T, Akahoshi T, Abdelkarim B, Jones MK, Tarnawski AS 2005 Survivin: a novel target for indomethacin-induced gastric injury.
Gastroenterology 128: 63-73.
*
-
Chiu HJ, Fischman DA, Hammerling U 2008 Vitamin A depletion causes oxidative stress, mitochondrial dysfunction, and PARP-1-dependent energy deprivation.
FASEB J. Aug 1 [Epub ahead of print].
*
-
Cho-Rok J, Yoo J, Jang YJ, Kim S, Chu IS, Yeom YI, Choi JY, Im DS 2006 Adenovirus-mediated transfer of siRNA against PTTG1 inhibits liver cancer cell growth in vitro and in vivo.
Hepatology 43: 1042-1052.
*
-
Choe SS, Choi AH, Lee JW, Kim KH, Chung JJ, Park J, Lee KM, Park KG, Lee IK, Kim JB 2007 Chronic activation of liver X receptor induces beta-cell apoptosis through hyperactivation of lipogenesis.
Diabetes 56: 1534-1543.
*
-
Choi KH, Lee EB, Yoo CD, Baek HJ, Kang SW, Shin KC, Lee YJ, Kim HA, Jeon JH, Kim CW, Shin DM, Kim IG, Son YW 2005 Clinical significance of anti-filaggrin antibody recognizing uncitrullinated filaggrin in rheumatoid arthritis.
Exp. Mol. Med. 37: 546-552.
*
-
Choi KS, Song EK, Yim CY 2008 Cytokines secreted by IL-2-activated lymphocytes induce endogenous nitric oxide synthesis and apoptosis in macrophages.
J. Leukoc. Biol. 83: 1440-1450.
*
-
Choi SS, Sicklick JK, Ma Q, Yang L, Huang J, Qi Y, Chen W, Li YX, Goldschmidt-Clermont PJ, Diehl AM 2006 Sustained activation of Rac1 in hepatic stellate cells promotes liver injury and fibrosis in mice.
Hepatology 44: 1267-1277.
*
-
| |
